Your browser is no longer supported. Please, upgrade your browser.
ISRG [NASD]
Intuitive Surgical, Inc.
IndexS&P 500 P/E66.45 EPS (ttm)4.63 Insider Own0.10% Shs Outstand356.80M Perf Week-5.10%
Market Cap111.81B Forward P/E55.42 EPS next Y5.55 Insider Trans-18.92% Shs Float353.52M Perf Month-7.21%
Income1.69B PEG3.86 EPS next Q1.28 Inst Own86.50% Short Float0.79% Perf Quarter-7.17%
Sales5.49B P/S20.37 EPS this Y-23.60% Inst Trans0.43% Short Ratio1.75 Perf Half Y-0.96%
Book/sh31.98 P/B9.62 EPS next Y11.96% ROA14.10% Target Price363.07 Perf Year18.60%
Cash/sh11.64 P/C26.43 EPS next 5Y17.21% ROE16.00% 52W Range227.47 - 369.69 Perf YTD-14.35%
Dividend- P/FCF59.32 EPS past 5Y11.20% ROI9.30% 52W High-16.76% Beta1.13
Dividend %- Quick Ratio5.00 Sales past 5Y12.80% Gross Margin69.10% 52W Low35.29% ATR9.54
Employees8081 Current Ratio5.60 Sales Q/Q30.20% Oper. Margin32.50% RSI (14)28.59 Volatility3.04% 2.72%
OptionableYes Debt/Eq0.00 EPS Q/Q19.60% Profit Margin30.80% Rel Volume1.43 Prev Close313.21
ShortableYes LT Debt/Eq0.00 EarningsJan 20 AMC Payout0.00% Avg Volume1.60M Price307.74
Recom2.20 SMA20-10.80% SMA50-10.71% SMA200-4.12% Volume2,280,783 Change-1.75%
Jan-10-22Upgrade BTIG Research Neutral → Buy $372
Oct-01-21Downgrade Citigroup Buy → Neutral $1100
Jul-21-21Reiterated Wells Fargo Overweight $916 → $1060
Jul-21-21Reiterated UBS Neutral $890 → $970
Jul-21-21Reiterated SVB Leerink Mkt Perform $930 → $975
Jul-21-21Reiterated Stifel Buy $1060 → $1100
Jul-21-21Reiterated Piper Sandler Neutral $840 → $970
Jul-21-21Reiterated Morgan Stanley Equal-Weight $855 → $930
Jul-21-21Reiterated JP Morgan Overweight $900 → $1000
Jul-21-21Reiterated Citigroup Buy $939 → $1100
Jul-21-21Reiterated BofA Securities Neutral $890 → $1020
Jul-14-21Reiterated Goldman Buy $953 → $1090
Jun-01-21Upgrade Evercore ISI Underperform → In-line
Apr-21-21Upgrade Robert W. Baird Neutral → Outperform $825 → $925
Apr-21-21Upgrade Oppenheimer Underperform → Perform
Apr-01-21Initiated Citigroup Buy $862
Dec-15-20Downgrade Morgan Stanley Overweight → Equal-Weight $780
Sep-28-20Initiated Argus Buy $775
Sep-11-20Initiated Wolfe Research Outperform $789
Sep-08-20Downgrade BofA Securities Buy → Neutral $725 → $760
Jan-14-22 06:00PM  
10:00AM  
Jan-13-22 03:00PM  
Jan-12-22 01:22PM  
09:18AM  
09:00AM  
Jan-10-22 07:39PM  
06:15PM  
03:45PM  
10:19AM  
05:52AM  
Jan-09-22 06:04AM  
Jan-07-22 10:45AM  
Jan-05-22 09:50AM  
Jan-03-22 05:52AM  
Dec-31-21 05:45PM  
07:20AM  
Dec-30-21 07:06AM  
Dec-29-21 05:50PM  
Dec-25-21 11:38AM  
Dec-24-21 06:38AM  
01:38AM  
Dec-23-21 05:45PM  
Dec-22-21 02:18PM  
Dec-21-21 01:30PM  
07:03AM  
Dec-20-21 05:50PM  
Dec-18-21 11:00AM  
03:38AM  
Dec-16-21 02:41PM  
Dec-15-21 09:38AM  
09:22AM  
08:45AM  
06:00AM  
Dec-14-21 01:38PM  
08:45AM  
Dec-13-21 05:45PM  
Dec-11-21 11:15AM  
Dec-10-21 02:02PM  
07:18AM  
Dec-09-21 06:38PM  
05:38PM  
Dec-08-21 10:45AM  
12:38AM  
Dec-07-21 04:26PM  
02:19PM  
12:53PM  
Dec-06-21 05:45PM  
Dec-01-21 06:11AM  
Nov-29-21 05:45PM  
Nov-27-21 10:45AM  
Nov-23-21 11:00AM  
Nov-20-21 06:14AM  
Nov-18-21 11:30AM  
Nov-17-21 06:12AM  
Nov-15-21 05:52AM  
Nov-07-21 05:15AM  
Nov-05-21 05:55AM  
Nov-04-21 05:52AM  
Nov-02-21 10:45AM  
10:30AM  
Nov-01-21 12:09PM  
09:45AM  
09:00AM  
05:55AM  
Oct-31-21 05:55AM  
Oct-28-21 08:08AM  
06:30AM  
05:55AM  
Oct-26-21 11:44AM  
Oct-25-21 06:00AM  
05:52AM  
Oct-22-21 11:21AM  
06:00AM  
Oct-20-21 10:02AM  
09:16AM  
08:18AM  
08:02AM  
07:10AM  
06:33AM  
05:55AM  
02:00AM  
Oct-19-21 04:15PM  
03:22PM  
02:45PM  
02:45PM  
12:03PM  
10:11AM  
09:29AM  
06:47AM  
Oct-18-21 09:05AM  
Oct-14-21 09:59AM  
Oct-13-21 12:27PM  
Oct-12-21 03:00PM  
10:15AM  
04:10AM  
Oct-11-21 05:51AM  
Oct-10-21 08:27AM  
Oct-09-21 06:23AM  
Oct-08-21 02:45PM  
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Johnson Amal MDirectorNov 24Option Exercise64.367,500482,70018,169Nov 26 09:20 PM
Johnson Amal MDirectorNov 24Sale333.737,5002,502,95410,669Nov 26 09:20 PM
MOHR MARSHALLExecutive VP & CFOOct 25Option Exercise59.2320,4751,212,68920,475Oct 26 05:10 PM
MOHR MARSHALLExecutive VP & CFOOct 25Sale339.2020,4756,945,1220Oct 26 05:10 PM
DeSantis RobertEVP & Chief Product OfficerOct 22Option Exercise208.791,014211,7081,365Oct 26 05:03 PM
Curet MyriamEVP & Chief Medical OfficerOct 22Option Exercise109.496,000656,9146,285Oct 26 05:05 PM
LEVY ALAN JDirectorOct 22Option Exercise62.717,500470,35528,782Oct 26 05:07 PM
Samath JamieSVP of FinanceOct 22Option Exercise174.391,503262,1131,086Oct 26 05:09 PM
Samath JamieSVP of FinanceOct 22Sale339.661,503510,510762Oct 26 05:09 PM
LEVY ALAN JDirectorOct 22Sale339.647,5002,547,28124,282Oct 26 05:07 PM
Curet MyriamEVP & Chief Medical OfficerOct 22Sale339.646,0002,037,830285Oct 26 05:05 PM
DeSantis RobertEVP & Chief Product OfficerOct 22Sale339.751,014344,5061,092Oct 26 05:03 PM
Curet MyriamEVP & Chief Medical OfficerSep 09Option Exercise302.124,2501,284,0123,095Sep 10 04:23 PM
RUBASH MARK JDirectorSep 09Option Exercise192.841,196230,6415,315Sep 13 04:31 PM
RUBASH MARK JDirectorSep 09Sale1083.161,1961,295,4594,815Sep 13 04:31 PM
Curet MyriamEVP & Chief Medical OfficerSep 09Sale1082.544,2504,600,78295Sep 10 04:23 PM
DeSantis RobertEVP & Chief Product OfficerAug 26Option Exercise736.80397292,510761Aug 27 01:13 PM
DeSantis RobertEVP & Chief Product OfficerAug 26Sale1048.12397416,104364Aug 27 01:13 PM
Johnson Amal MDirectorAug 11Option Exercise193.082,500482,7006,223Aug 12 04:25 PM
Johnson Amal MDirectorAug 11Sale1001.632,5002,504,0873,723Aug 12 04:25 PM
Rosa David J.EVP & Chief Business OfficerAug 06Option Exercise172.4410,5001,810,58545,566Aug 09 06:53 PM
Rosa David J.EVP & Chief Business OfficerAug 06Sale1011.908,0658,160,97737,501Aug 09 06:53 PM
Rosa David J.EVP & Chief Business OfficerAug 05Option Exercise172.4410,5001,810,58543,212Aug 09 06:53 PM
Rosa David J.EVP & Chief Business OfficerAug 05Sale1007.238,1468,204,92735,066Aug 09 06:53 PM
Leonard Keith RDirectorAug 03Option Exercise462.71996460,8591,845Aug 03 07:39 PM
Leonard Keith RDirectorAug 03Sale1000.00996996,000849Aug 03 07:39 PM
MOHR MARSHALLExecutive VP & CFOJul 26Option Exercise171.336,8251,169,3506,825Jul 27 06:41 PM
MOHR MARSHALLExecutive VP & CFOJul 26Sale963.386,8256,575,0810Jul 27 06:41 PM
LEVY ALAN JDirectorJul 23Option Exercise165.612,500414,0309,469Jul 26 07:06 PM
BARRATT CRAIG HDirectorJul 23Option Exercise161.271,275205,6151,275Jul 26 07:27 PM
Samath JamieSVP of FinanceJul 23Option Exercise523.65503263,397361Jul 26 07:37 PM
DeSantis RobertEVP & Chief Product OfficerJul 23Option Exercise602.791,389837,2763,462Jul 26 07:44 PM
DeSantis RobertEVP & Chief Product OfficerJul 23Sale967.264,0043,872,925363Jul 26 07:44 PM
Samath JamieSVP of FinanceJul 23Sale971.64503488,735253Jul 26 07:37 PM
BARRATT CRAIG HDirectorJul 23Sale967.201,2751,233,1790Jul 26 07:27 PM
Ladd Amy LDirectorJul 23Sale971.64128124,370255Jul 26 07:17 PM
LEVY ALAN JDirectorJul 23Sale967.362,5002,418,4088,094Jul 26 07:06 PM
Rosa David J.EVP and Chief Business OfficerJun 15Option Exercise168.4121,0003,536,61049,750Jun 16 06:01 PM
Rosa David J.EVP and Chief Business OfficerJun 15Sale873.2317,03814,878,11032,712Jun 16 06:01 PM
Johnson Amal MDirectorMay 12Option Exercise193.082,500482,7006,223May 13 12:01 PM
Johnson Amal MDirectorMay 12Sale817.822,5002,044,5573,723May 13 12:01 PM
GUTHART GARY SPresident & CEOMay 04Option Exercise168.4114,0002,357,74014,000May 05 04:40 PM
GUTHART GARY SPresident & CEOMay 04Sale851.9910,6179,045,5913,383May 05 04:40 PM
MOHR MARSHALLExecutive VP & CFOApr 26Option Exercise166.4530,3755,055,98421,000Apr 27 08:24 PM
Myriam CuretEVP & Chief Medical OfficerApr 26Option Exercise238.91875209,049969Apr 27 12:28 PM
Myriam CuretEVP & Chief Medical OfficerApr 26Sale866.44875758,13594Apr 27 12:28 PM
MOHR MARSHALLExecutive VP & CFOApr 26Sale865.6921,96319,013,2220Apr 27 08:24 PM
LEVY ALAN JDirectorApr 23Option Exercise161.272,500403,16710,594Apr 26 03:09 PM
Andersen Reiter KaraSr VP General Counsel & CCOApr 23Option Exercise170.76750128,0685,594Apr 26 02:37 PM
Samath JamieSVP of FinanceApr 23Option Exercise532.62793422,370480Apr 27 12:24 PM
Samath JamieSVP of FinanceApr 23Sale848.58793672,924253Apr 27 12:24 PM
Andersen Reiter KaraSr VP General Counsel & CCOApr 23Sale848.01750636,0084,844Apr 26 02:37 PM
LEVY ALAN JDirectorApr 23Sale856.792,5002,141,9708,094Apr 26 03:09 PM
RUBASH MARK JDirectorApr 22Option Exercise0.0025504,815Apr 26 03:18 PM
NACHTSHEIM JAMI KDirectorApr 22Option Exercise0.0025501,342Apr 26 02:45 PM
LEVY ALAN JDirectorApr 22Option Exercise0.0025508,094Apr 26 03:09 PM
Leonard Keith RDirectorApr 22Option Exercise0.002550849Apr 26 03:05 PM
Ladd Amy LDirectorApr 22Option Exercise0.002550383Apr 26 03:00 PM
KANIA DON RDirectorApr 22Option Exercise0.002550744Apr 26 02:56 PM
Johnson Amal MDirectorApr 22Option Exercise0.0025503,723Apr 23 07:12 PM
Beery Joseph CDirectorApr 22Option Exercise0.002550255Apr 23 07:01 PM
Myriam CuretEVP & Chief Medical OfficerMar 02Sale760.00379288,04094Mar 02 06:12 PM
Samath JamieSVP of FinanceMar 02Sale760.00215163,400253Mar 02 05:37 PM
GUTHART GARY SPresident & CEOFeb 28Option Exercise0.001,28906,621Mar 02 06:21 PM
Myriam CuretEVP & Chief Medical OfficerFeb 28Option Exercise0.007520846Mar 02 06:12 PM
MOHR MARSHALLExecutive VP & CFOFeb 28Option Exercise0.00752010,592Mar 02 05:58 PM
Rosa David J.EVP and Chief Business OfficerFeb 28Option Exercise0.00752029,123Mar 02 02:38 PM
DeSantis RobertExecutive VP & GM IA&EFeb 28Option Exercise0.0072503,264Mar 02 02:02 PM
Andersen Reiter KaraSr VP General Counsel & CCOFeb 28Option Exercise0.0037605,031Mar 02 03:23 PM
Samath JamieSVP of FinanceFeb 28Option Exercise0.004190672Mar 02 05:37 PM
DeSantis RobertExecutive VP & GM IA&EFeb 17Sale782.002,9582,313,1562,539Feb 17 06:53 PM
Myriam CuretEVP & Chief Medical OfficerFeb 17Sale782.001,4851,161,27094Feb 17 06:23 PM
Samath JamieSVP of FinanceFeb 17Sale782.00655512,210253Feb 17 06:14 PM
DeSantis RobertExecutive VP & GM IA&EFeb 15Option Exercise0.003,16606,088Feb 17 06:53 PM
Myriam CuretEVP & Chief Medical OfficerFeb 15Option Exercise0.002,58201,786Feb 17 06:23 PM
Samath JamieSVP of FinanceFeb 15Option Exercise0.001,00301,072Feb 17 06:14 PM
Andersen Reiter KaraSr VP General Counsel & CCOFeb 15Option Exercise0.001,76804,990Feb 17 05:32 PM
Rosa David J.EVP and Chief Business OfficerFeb 15Option Exercise0.003,292028,743Feb 17 05:14 PM
GUTHART GARY SPresident & CEOFeb 15Option Exercise0.004,66705,952Feb 17 05:07 PM
MOHR MARSHALLExecutive VP & CFOFeb 15Option Exercise56.863,791215,54611,090Feb 17 08:31 PM
MOHR MARSHALLExecutive VP & CFOFeb 11Option Exercise168.4121,0003,536,61021,048Feb 12 12:24 PM
MOHR MARSHALLExecutive VP & CFOFeb 11Sale800.0012,4879,989,6028,561Feb 12 12:24 PM
GUTHART GARY SPresident & CEOFeb 02Option Exercise168.4114,0002,357,74014,000Feb 03 04:21 PM
GUTHART GARY SPresident & CEOFeb 02Sale762.1411,0208,398,7592,980Feb 03 04:21 PM
MOHR MARSHALLExecutive VP & CFOJan 29Option Exercise148.039,3751,387,7819,423Feb 01 04:06 PM
MOHR MARSHALLExecutive VP & CFOJan 29Sale751.669,3757,046,85848Feb 01 04:06 PM
Andersen Reiter KaraSr VP General Counsel & CCOJan 26Option Exercise170.761,250213,4465,318Jan 27 01:45 PM
LEVY ALAN JDirectorJan 26Option Exercise161.272,500403,16710,339Jan 27 01:07 PM
Samath JamieSVP of FinanceJan 26Option Exercise399.91521208,355326Jan 27 02:02 PM
Samath JamieSVP of FinanceJan 26Sale754.48521393,084207Jan 27 02:02 PM
LEVY ALAN JDirectorJan 26Sale754.482,5001,886,2007,839Jan 27 01:07 PM
Andersen Reiter KaraSr VP General Counsel & CCOJan 26Sale754.481,6521,246,4013,666Jan 27 01:45 PM
PRTA Prothena Corporation plc daily Stock Chart
PRTA [NASD]
Prothena Corporation plc
Index- P/E38.23 EPS (ttm)1.03 Insider Own0.05% Shs Outstand45.63M Perf Week-4.03%
Market Cap1.74B Forward P/E- EPS next Y-2.06 Insider Trans- Shs Float25.13M Perf Month-12.47%
Income69.40M PEG- EPS next Q-0.57 Inst Own89.50% Short Float9.83% Perf Quarter-37.71%
Sales199.80M P/S8.69 EPS this Y-43.00% Inst Trans-0.02% Short Ratio6.18 Perf Half Y-20.94%
Book/sh10.75 P/B3.68 EPS next Y-241.10% ROA15.60% Target Price82.22 Perf Year190.88%
Cash/sh13.67 P/C2.89 EPS next 5Y-0.60% ROE23.20% 52W Range10.72 - 79.75 Perf YTD-19.98%
Dividend- P/FCF18.13 EPS past 5Y-0.90% ROI-61.10% 52W High-50.43% Beta1.28
Dividend %- Quick Ratio20.80 Sales past 5Y-11.90% Gross Margin- 52W Low268.75% ATR3.52
Employees66 Current Ratio20.80 Sales Q/Q88545.90% Oper. Margin37.50% RSI (14)37.58 Volatility9.38% 7.53%
OptionableYes Debt/Eq0.00 EPS Q/Q378.50% Profit Margin34.80% Rel Volume1.62 Prev Close37.24
ShortableYes LT Debt/Eq0.00 EarningsNov 04 AMC Payout0.00% Avg Volume399.28K Price39.53
Recom1.70 SMA20-12.22% SMA50-19.70% SMA200-19.93% Volume646,481 Change6.15%
Nov-19-21Initiated JMP Securities Mkt Outperform $77
Jun-18-21Upgrade BofA Securities Underperform → Neutral $12 → $49
Jun-08-21Reiterated Oppenheimer Outperform $45 → $54
May-26-21Initiated Citigroup Buy $39
Feb-26-21Upgrade RBC Capital Mkts Sector Perform → Outperform $14 → $28
Feb-12-21Upgrade Jefferies Hold → Buy $15 → $30
Feb-02-21Upgrade BTIG Research Neutral → Buy $29
Dec-07-20Initiated H.C. Wainwright Buy $22
Jul-09-20Upgrade Oppenheimer Perform → Outperform $16
Nov-19-19Upgrade Evercore ISI In-line → Outperform $14
May-21-18Downgrade Barclays Equal Weight → Underweight $14 → $12
Apr-23-18Downgrade Jefferies Buy → Hold
Apr-05-18Reiterated Barclays Overweight $70 → $50
Nov-20-17Downgrade Wedbush Outperform → Neutral $75 → $55
Sep-29-17Reiterated BTIG Research Buy $80 → $77
Sep-15-17Initiated RBC Capital Mkts Outperform $87
Aug-17-17Initiated Evercore ISI Outperform $83
Jul-11-17Initiated Jefferies Buy
Apr-12-17Initiated Piper Jaffray Overweight $69
Apr-12-17Initiated Cantor Fitzgerald Overweight $86
Jan-10-22 11:02AM  
Dec-23-21 08:09AM  
Dec-12-21 03:55PM  
Dec-07-21 01:51PM  
Dec-03-21 11:58AM  
Nov-29-21 04:05PM  
Nov-25-21 08:25AM  
Nov-22-21 10:38AM  
Nov-18-21 08:43AM  
Nov-10-21 09:14AM  
Nov-05-21 08:59AM  
Nov-04-21 08:56PM  
04:05PM  
11:16AM  
Nov-01-21 11:26AM  
Oct-28-21 04:05PM  
11:40AM  
Oct-27-21 03:03PM  
Oct-26-21 02:03PM  
Oct-23-21 06:08AM  
Oct-15-21 09:34AM  
Oct-12-21 11:40AM  
09:10AM  
Oct-11-21 01:06PM  
Oct-04-21 11:54AM  
Oct-01-21 04:30PM  
04:05PM  
Sep-23-21 11:40AM  
Sep-18-21 09:13AM  
Sep-09-21 12:00PM  
Sep-03-21 04:05PM  
Sep-01-21 04:05PM  
11:30AM  
Aug-25-21 04:46AM  
Aug-11-21 08:02AM  
Aug-09-21 01:32AM  
Aug-06-21 12:41PM  
Aug-05-21 05:25PM  
04:05PM  
Aug-03-21 11:33AM  
09:01AM  
Jul-29-21 04:05PM  
03:05PM  
Jul-26-21 03:27PM  
09:00AM  
Jul-20-21 04:05PM  
Jul-17-21 07:37AM  
Jul-16-21 11:40AM  
07:18AM  
Jul-14-21 03:21PM  
Jul-13-21 12:22PM  
Jul-12-21 12:45PM  
08:30AM  
07:08AM  
07:00AM  
07:00AM  
03:52AM  
Jun-24-21 08:30AM  
Jun-18-21 04:53AM  
Jun-10-21 04:19PM  
02:18PM  
11:30AM  
Jun-09-21 04:58AM  
May-20-21 04:05PM  
May-12-21 03:32PM  
May-11-21 04:05PM  
06:57AM  
May-10-21 04:05PM  
10:40AM  
May-07-21 04:05PM  
08:52AM  
May-04-21 04:05PM  
Apr-28-21 12:33PM  
Apr-18-21 03:05PM  
Apr-15-21 04:05PM  
Apr-07-21 04:05PM  
Apr-05-21 04:05PM  
Mar-29-21 08:22AM  
Mar-25-21 11:37AM  
Mar-24-21 08:00AM  
Mar-23-21 04:29PM  
Mar-13-21 10:30AM  
Mar-11-21 08:19AM  
Mar-08-21 04:05PM  
Feb-24-21 04:05PM  
Feb-12-21 05:11PM  
Feb-11-21 09:19AM  
09:15AM  
08:00AM  
06:30AM  
Feb-05-21 04:05PM  
Feb-04-21 04:05PM  
Feb-03-21 12:30PM  
Feb-01-21 04:15PM  
Dec-09-20 08:00AM  
Dec-04-20 04:05PM  
11:31AM  
Nov-27-20 12:25AM  
Nov-16-20 02:56AM  
Nov-05-20 11:13AM  
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing PRX002/RG7935 that is in Phase 2 clinical trial for treating Parkinson's disease and other related synucleinopathies; and PRX004, an antibody that is in Phase 1 clinical trial for the treatment of ATTR amyloidosis. Its discovery-stage programs include Tau for treating Alzheimer's disease, frontotemporal dementia, progressive supranuclear palsy, chronic traumatic encephalopathy, and other tauopathies; A, or Amyloid Beta, a protein for the treatment of Alzheimer's disease; TDP-43 for amyotrophic lateral sclerosis and frontotemporal dementia; and other products for neurodegenerative diseases. The company has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein; and a collaboration agreement with Bristol-Myers Squibb to develop antibodies. Prothena Corporation plc was founded in 2012 and is based in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EcoR1 Capital, LLC10% OwnerJan 12Buy37.50300,00011,250,30011,584,280Jan 12 06:12 PM
Selkoe Dennis J.DirectorJan 03Option Exercise9.235,00046,1507,845Jan 05 09:02 PM
Selkoe Dennis J.DirectorJan 03Sale47.455,000237,2332,845Jan 05 09:02 PM
Walker Karin LChief Accounting OfficerNov 23Option Exercise15.044,51967,9664,519Nov 26 09:19 PM
Walker Karin LChief Accounting OfficerNov 23Sale57.884,519261,5730Nov 26 09:19 PM
Malecek Michael JSee RemarksNov 19Option Exercise10.2710,000102,70010,000Nov 19 09:32 PM
Malecek Michael JSee RemarksNov 19Sale55.0010,000550,0000Nov 19 09:32 PM
Karp Carol D.Chief Regulatory OfficerNov 01Option Exercise15.0410,000150,40010,000Nov 03 09:17 PM
Karp Carol D.Chief Regulatory OfficerNov 01Sale57.1810,000571,8180Nov 03 09:17 PM
Malecek Michael JSee RemarksOct 27Option Exercise10.2710,000102,70010,000Oct 29 05:00 PM
Malecek Michael JSee RemarksOct 27Sale58.5210,000585,2500Oct 29 05:00 PM
Walker Karin LChief Accounting OfficerOct 20Option Exercise16.9723,000390,23023,000Oct 22 05:53 PM
Walker Karin LChief Accounting OfficerOct 20Sale60.2523,0001,385,8230Oct 22 05:53 PM
Karp Carol D.Chief Regulatory OfficerOct 01Option Exercise15.0410,000150,40010,000Oct 01 08:46 PM
Selkoe Dennis J.DirectorOct 01Option Exercise9.235,00046,1507,845Oct 01 09:18 PM
Selkoe Dennis J.DirectorOct 01Sale67.845,000339,1762,845Oct 01 09:18 PM
Karp Carol D.Chief Regulatory OfficerOct 01Sale68.2310,000682,3360Oct 01 08:46 PM
Karp Carol D.Chief Regulatory OfficerSep 09Option Exercise15.0410,000150,40010,000Sep 10 05:06 PM
Karp Carol D.Chief Regulatory OfficerSep 09Sale71.9810,000719,8470Sep 10 05:06 PM
Selkoe Dennis J.DirectorJul 30Option Exercise14.265,00071,3157,845Jul 30 08:04 PM
Selkoe Dennis J.DirectorJul 30Sale49.475,000247,3742,845Jul 30 08:04 PM
HENNEY CHRISTOPHER SDirectorJul 14Option Exercise11.3311,108125,85411,108Jul 16 04:02 PM
HENNEY CHRISTOPHER SDirectorJul 14Sale55.4611,108616,0200Jul 16 04:02 PM
HENNEY CHRISTOPHER SDirectorJul 12Option Exercise9.7923,892233,94617,500Jul 12 09:37 PM
HENNEY CHRISTOPHER SDirectorJul 12Sale55.5123,8921,326,1280Jul 12 09:37 PM
HENNEY CHRISTOPHER SDirectorJun 25Option Exercise16.4312,000197,16012,000Jun 29 06:13 PM
HENNEY CHRISTOPHER SDirectorJun 25Sale47.7312,000572,8190Jun 29 06:13 PM
Zago Wagner M.Chief Scientific OfficerJun 22Option Exercise17.81115,2502,052,940115,250Jun 24 04:38 PM
Zago Wagner M.Chief Scientific OfficerJun 22Sale46.15115,2505,318,7690Jun 24 04:38 PM
EcoR1 Capital, LLC10% OwnerMar 24Buy20.75875,00018,156,25011,034,280Mar 25 11:14 AM
EcoR1 Capital, LLC10% OwnerFeb 24Buy22.0210,800237,86710,159,280Feb 25 06:00 PM
EcoR1 Capital, LLC10% OwnerFeb 23Buy21.0544,400934,51810,148,480Feb 25 06:00 PM
Zago Wagner M.Chief Scientific OfficerFeb 18Option Exercise6.417,54048,3317,540Feb 19 06:39 PM
EcoR1 Capital, LLC10% OwnerFeb 18Buy3.6844,100162,10310,104,080Feb 22 04:24 PM
Zago Wagner M.Chief Scientific OfficerFeb 18Sale25.507,540192,2700Feb 19 06:39 PM
EcoR1 Capital, LLC10% OwnerFeb 17Buy23.46198,8404,665,54210,059,980Feb 17 07:14 PM
EcoR1 Capital, LLC10% OwnerFeb 16Buy22.7889,2002,031,9679,861,140Feb 17 07:14 PM
Zago Wagner M.Chief Scientific OfficerFeb 12Option Exercise11.4826,310302,14718,750Feb 17 06:47 PM
EcoR1 Capital, LLC10% OwnerFeb 12Buy20.16345,3006,959,7619,771,940Feb 17 07:14 PM
Zago Wagner M.Chief Scientific OfficerFeb 12Sale19.1626,310504,0570Feb 17 06:47 PM
UPST Upstart Holdings, Inc. daily Stock Chart
UPST [NASD]
Upstart Holdings, Inc.
Index- P/E135.33 EPS (ttm)0.82 Insider Own0.90% Shs Outstand79.39M Perf Week-4.99%
Market Cap8.95B Forward P/E47.34 EPS next Y2.35 Insider Trans-91.20% Shs Float69.98M Perf Month-27.96%
Income77.50M PEG- EPS next Q0.51 Inst Own53.00% Short Float8.00% Perf Quarter-71.51%
Sales598.30M P/S14.97 EPS this Y747.80% Inst Trans1.44% Short Ratio1.07 Perf Half Y-3.62%
Book/sh9.06 P/B12.26 EPS next Y20.48% ROA8.90% Target Price255.30 Perf Year98.41%
Cash/sh12.92 P/C8.60 EPS next 5Y- ROE15.10% 52W Range42.51 - 401.49 Perf YTD-26.56%
Dividend- P/FCF36.85 EPS past 5Y- ROI3.10% 52W High-72.33% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin85.10% 52W Low161.37% ATR12.87
Employees554 Current Ratio- Sales Q/Q234.50% Oper. Margin15.20% RSI (14)30.93 Volatility9.02% 9.16%
OptionableYes Debt/Eq0.90 EPS Q/Q127.10% Profit Margin13.00% Rel Volume0.92 Prev Close109.25
ShortableYes LT Debt/Eq0.90 EarningsNov 09 AMC Payout0.00% Avg Volume5.24M Price111.11
Recom2.40 SMA20-18.34% SMA50-40.74% SMA200-40.69% Volume4,825,489 Change1.70%
Dec-22-21Initiated Wedbush Neutral $160
Dec-09-21Initiated Morgan Stanley Equal-Weight $200
Dec-03-21Upgrade Citigroup Neutral → Buy $350
Oct-26-21Downgrade Jefferies Buy → Hold $160 → $330
Oct-18-21Downgrade BofA Securities Neutral → Underperform $300
Oct-18-21Downgrade BofA Securities Buy → Underperform $300
Sep-20-21Downgrade Citigroup Buy → Neutral $350
Sep-07-21Initiated Atlantic Equities Overweight $290
Aug-13-21Upgrade Barclays Equal Weight → Overweight $130 → $230
Aug-11-21Upgrade Citigroup Neutral → Buy $120 → $205
Jul-12-21Initiated Goldman Buy $147
Apr-27-21Initiated Piper Sandler Overweight $143
Mar-18-21Upgrade JMP Securities Mkt Perform → Mkt Outperform $111
Mar-18-21Upgrade BofA Securities Neutral → Buy $57 → $135
Jan-11-21Initiated JMP Securities Mkt Perform
Jan-11-21Initiated Jefferies Buy $66
Jan-11-21Initiated Goldman Neutral $55
Jan-11-21Initiated BofA Securities Neutral $57
Jan-11-21Initiated Barclays Equal Weight $58
Jan-15-22 07:45AM  
07:24AM  
07:20AM  
Jan-14-22 05:45PM  
Jan-13-22 01:38PM  
01:15PM  
Jan-12-22 05:38PM  
04:56PM  
02:35PM  
09:38AM  
09:00AM  
06:00AM  
Jan-11-22 07:07PM  
11:53AM  
07:00AM  
Jan-08-22 07:13PM  
Jan-07-22 08:34AM  
08:15AM  
07:50AM  
Jan-06-22 04:25PM  
11:00AM  
07:15AM  
Jan-05-22 04:03PM  
02:29PM  
01:55PM  
01:54PM  
08:12AM  
07:20AM  
06:19AM  
Jan-04-22 01:17PM  
10:38AM  
08:29AM  
Jan-03-22 04:06PM  
11:55AM  
06:50AM  
Jan-02-22 08:30AM  
Dec-31-21 11:15AM  
07:25AM  
Dec-30-21 05:37PM  
Dec-29-21 05:06PM  
07:15AM  
Dec-28-21 05:55PM  
10:05AM  
08:30AM  
Dec-27-21 08:38PM  
12:02PM  
Dec-23-21 06:31PM  
04:45PM  
11:33AM  
Dec-22-21 05:06AM  
Dec-21-21 11:47PM  
04:01PM  
03:26PM  
06:45AM  
06:26AM  
Dec-18-21 05:01AM  
12:38AM  
Dec-16-21 11:36AM  
07:35AM  
06:19AM  
Dec-15-21 11:17AM  
09:29AM  
08:45AM  
Dec-14-21 05:34PM  
04:30PM  
07:30AM  
Dec-13-21 05:08PM  
Dec-11-21 06:25PM  
08:35AM  
06:38AM  
06:38AM  
Dec-10-21 10:59AM  
07:40AM  
Dec-09-21 04:22PM  
11:28AM  
09:00AM  
07:05AM  
Dec-08-21 01:30PM  
09:00AM  
07:15AM  
06:45AM  
Dec-07-21 05:53PM  
08:15AM  
06:38AM  
Dec-04-21 03:17PM  
Dec-03-21 05:01PM  
03:41PM  
Dec-02-21 10:30AM  
08:29AM  
07:15AM  
Dec-01-21 07:35AM  
06:10AM  
Nov-29-21 07:12AM  
Nov-28-21 12:14PM  
08:20AM  
05:59AM  
Nov-27-21 01:18PM  
Nov-26-21 07:00AM  
Nov-24-21 03:48PM  
12:08PM  
Upstart Holdings, Inc. operates a cloud- based artificial intelligence (AI) lending platform. The company's platform aggregates consumer demand for loans and connects it to its network of the company's AI- enabled bank partners. Its platform connects consumers, banks, and institutional investors through a shared AI lending platform. Upstart Holdings, Inc. was incorporated in 2012 and is headquartered in San Mateo, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nicoll AlisonGeneral CounselJan 12Option Exercise0.437,5003,225186,780Jan 14 04:56 PM
Nicoll AlisonGeneral CounselJan 12Sale121.747,500913,079179,280Jan 14 04:56 PM
Nicoll AlisonGeneral CounselJan 05Option Exercise0.307,5002,225186,780Jan 07 05:43 PM
Nicoll AlisonGeneral CounselJan 05Sale132.757,500995,589179,280Jan 07 05:43 PM
Gu PaulSVP, Product and Data ScienceJan 04Option Exercise2.6441,708110,297459,120Jan 06 07:32 PM
Girouard DaveChief Executive OfficerJan 03Sale150.468,3321,253,666563,165Jan 05 08:46 PM
Girouard DaveChief Executive OfficerJan 03Sale148.4883,33312,372,89353,308Jan 05 08:46 PM
Nicoll AlisonGeneral CounselDec 29Option Exercise0.237,5001,725186,780Dec 30 06:08 PM
Nicoll AlisonGeneral CounselDec 29Sale146.417,5001,098,062179,280Dec 30 06:08 PM
Nicoll AlisonGeneral CounselDec 22Option Exercise1.49172,550256,583186,780Dec 23 04:18 PM
Nicoll AlisonGeneral CounselDec 22Sale145.887,5001,094,084179,280Dec 23 04:18 PM
Nicoll AlisonGeneral CounselDec 15Option Exercise0.237,5001,72521,730Dec 17 04:51 PM
Nicoll AlisonGeneral CounselDec 15Sale146.247,5001,096,82714,230Dec 17 04:51 PM
Nicoll AlisonGeneral CounselDec 08Option Exercise0.237,5001,72521,730Dec 10 04:45 PM
Nicoll AlisonGeneral CounselDec 08Sale191.837,5001,438,69614,230Dec 10 04:45 PM
Loeb Daniel S10% OwnerDec 03Sale178.22395,00070,396,9418,100,000Dec 03 05:43 PM
Loeb Daniel S10% OwnerDec 02Sale172.09805,000138,530,1638,495,000Dec 03 05:40 PM
Nicoll AlisonGeneral CounselDec 01Option Exercise0.237,5001,72521,730Dec 03 08:48 PM
Girouard DaveChief Executive OfficerDec 01Sale202.4512,4982,530,184567,331Dec 03 09:12 PM
Girouard DaveChief Executive OfficerDec 01Sale194.10125,00024,263,06053,308Dec 03 09:10 PM
Nicoll AlisonGeneral CounselDec 01Sale194.217,5001,456,57714,230Dec 03 08:48 PM
Mirgorodskaya NataliaCorporate ControllerNov 26Sale201.3025952,13722,470Nov 30 06:56 PM
Nicoll AlisonGeneral CounselNov 24Option Exercise0.237,5001,72521,730Nov 29 07:34 PM
Nicoll AlisonGeneral CounselNov 24Sale203.737,5001,527,98914,230Nov 29 07:34 PM
Mirgorodskaya NataliaCorporate ControllerNov 23Sale198.5227855,19022,729Nov 24 05:47 PM
Loeb Daniel S10% OwnerNov 23Sale198.14200,00039,628,0909,300,000Nov 26 08:22 PM
Singh Cassidy SukhinderDirectorNov 19Option Exercise8.415,00042,0506,491Nov 23 04:27 PM
Loeb Daniel S10% OwnerNov 19Sale212.96750,000159,723,0279,500,000Nov 23 05:10 PM
Singh Cassidy SukhinderDirectorNov 19Sale211.765,0001,058,8001,491Nov 23 04:27 PM
Nicoll AlisonGeneral CounselNov 17Option Exercise0.2312,5002,87526,730Nov 19 04:55 PM
Nicoll AlisonGeneral CounselNov 17Sale238.4712,5002,980,81614,230Nov 19 04:55 PM
Gu PaulSVP, Product and Data ScienceNov 15Option Exercise1.0489,00092,270456,412Nov 17 07:54 PM
Hentges MaryDirectorNov 15Option Exercise3.8930,000116,70031,491Nov 17 08:00 PM
Loeb Daniel S10% OwnerNov 15Sale238.542,150,000512,865,04910,250,000Nov 17 05:39 PM
Hentges MaryDirectorNov 15Sale245.8930,0007,376,5621,491Nov 17 08:00 PM
Gu PaulSVP, Product and Data ScienceNov 15Sale244.9439,0009,552,761417,412Nov 17 07:54 PM
Terry Hilliard C. IIIDirectorNov 11Option Exercise3.8060,000228,00061,491Nov 15 05:58 PM
Terry Hilliard C. IIIDirectorNov 11Sale251.1560,00015,069,1921,491Nov 15 05:58 PM
Nicoll AlisonGeneral CounselNov 10Option Exercise0.2322,5005,17536,730Nov 12 04:10 PM
Gu PaulSVP, Product and Data ScienceNov 10Option Exercise1.3525,00033,750367,412Nov 12 04:06 PM
Nicoll AlisonGeneral CounselNov 10Sale255.2022,5005,742,01414,230Nov 12 04:10 PM
Gu PaulSVP, Product and Data ScienceNov 09Option Exercise1.3525,00033,750342,412Nov 12 04:06 PM
Nicoll AlisonGeneral CounselNov 03Option Exercise0.2322,5005,17536,730Nov 05 05:16 PM
Nicoll AlisonGeneral CounselNov 03Sale328.9322,5007,400,82314,230Nov 05 05:16 PM
Girouard DaveChief Executive OfficerNov 01Sale330.0212,4984,124,533981,253Nov 03 05:11 PM
Girouard DaveChief Executive OfficerNov 01Sale336.95125,00042,119,34153,308Nov 03 05:09 PM
Nicoll AlisonGeneral CounselOct 27Option Exercise0.2322,5005,17536,730Oct 29 06:17 PM
Gu PaulSVP, Product and Data ScienceOct 27Option Exercise1.3520,00027,000317,412Oct 29 06:20 PM
Nicoll AlisonGeneral CounselOct 27Sale320.7822,5007,217,45414,230Oct 29 06:17 PM
Gu PaulSVP, Product and Data ScienceOct 26Option Exercise1.3520,00027,000297,412Oct 28 04:53 PM
Nicoll AlisonGeneral CounselOct 20Option Exercise0.2322,5005,17536,730Oct 22 04:45 PM
Nicoll AlisonGeneral CounselOct 20Sale359.8722,5008,096,98414,230Oct 22 04:45 PM
Gu PaulSVP, Product and Data ScienceOct 15Option Exercise0.29155,00045,275432,412Oct 19 06:25 PM
Gu PaulSVP, Product and Data ScienceOct 15Sale390.73155,00060,562,986277,412Oct 19 06:25 PM
Nicoll AlisonGeneral CounselOct 13Option Exercise0.2322,5005,17536,730Oct 15 04:22 PM
Nicoll AlisonGeneral CounselOct 13Sale337.3422,5007,590,07814,230Oct 15 04:22 PM
Nicoll AlisonGeneral CounselOct 06Option Exercise0.2322,5005,17536,730Oct 08 04:32 PM
Nicoll AlisonGeneral CounselOct 06Sale301.0022,5006,772,49814,230Oct 08 04:32 PM
Girouard DaveChief Executive OfficerOct 01Sale309.1012,4983,863,074987,502Oct 05 08:52 PM
Girouard DaveChief Executive OfficerOct 01Sale301.60125,00037,700,41253,308Oct 05 08:51 PM
Nicoll AlisonGeneral CounselSep 29Option Exercise0.2322,5005,17536,730Oct 01 05:09 PM
Nicoll AlisonGeneral CounselSep 29Sale324.3222,5007,297,20614,230Oct 01 05:09 PM
Nicoll AlisonGeneral CounselSep 22Option Exercise0.2322,5005,17536,730Sep 24 04:41 PM
Nicoll AlisonGeneral CounselSep 22Sale321.6522,5007,237,16414,230Sep 24 04:41 PM
Nicoll AlisonGeneral CounselSep 15Option Exercise0.2322,5005,17536,730Sep 17 08:35 PM
Gu PaulSVP, Product and Data ScienceSep 15Option Exercise0.23155,00035,650432,412Sep 17 08:37 PM
Gu PaulSVP, Product and Data ScienceSep 15Sale270.40155,00041,911,898277,412Sep 17 08:37 PM
Nicoll AlisonGeneral CounselSep 15Sale270.8822,5006,094,71114,230Sep 17 08:35 PM
Nicoll AlisonGeneral CounselSep 08Option Exercise0.2322,5005,17536,730Sep 10 06:14 PM
Nicoll AlisonGeneral CounselSep 08Sale269.7522,5006,069,28914,230Sep 10 06:14 PM
Nicoll AlisonGeneral CounselSep 01Option Exercise0.2322,5005,17536,730Sep 03 08:12 PM
Girouard DaveChief Executive OfficerSep 01Sale225.5412,4982,818,763993,751Sep 03 08:33 PM
Girouard DaveChief Executive OfficerSep 01Sale225.43125,00028,179,35053,308Sep 03 08:33 PM
Nicoll AlisonGeneral CounselSep 01Sale225.4122,5005,071,83614,230Sep 03 08:12 PM
Nicoll AlisonGeneral CounselAug 25Option Exercise0.2322,5005,17536,730Aug 27 07:56 PM
Nicoll AlisonGeneral CounselAug 25Sale217.9822,5004,904,45714,230Aug 27 07:56 PM
Mirgorodskaya NataliaCorporate ControllerAug 25Sale218.8027159,29523,007Aug 27 07:55 PM
Loeb Daniel S10% OwnerAug 24Sale208.69100,00020,869,38012,400,000Aug 24 05:05 PM
Loeb Daniel S10% OwnerAug 23Sale202.62484,40098,147,72312,500,000Aug 24 05:05 PM
Loeb Daniel S10% OwnerAug 20Sale199.62396,82279,214,28212,984,400Aug 24 05:05 PM
Mirgorodskaya NataliaCorporate ControllerAug 20Sale195.6426752,23623,278Aug 24 07:59 PM
Counselman Anna M.SVP, People and OperationsAug 19Option Exercise0.19608,355115,253620,585Aug 23 07:49 PM
Gu PaulSVP, Product and Data ScienceAug 19Option Exercise1.3520,00027,000277,412Aug 23 07:47 PM
Counselman Anna M.SVP, People and OperationsAug 19Sale201.73608,355122,725,21312,230Aug 23 07:49 PM
Nicoll AlisonGeneral CounselAug 18Option Exercise0.2322,5005,17536,730Aug 20 06:18 PM
Nicoll AlisonGeneral CounselAug 18Sale213.9322,5004,813,44114,230Aug 20 06:18 PM
Gu PaulSVP, Product and Data ScienceAug 16Option Exercise0.17155,00026,300410,412Aug 18 08:18 PM
Gu PaulSVP, Product and Data ScienceAug 16Sale201.88155,00031,291,267255,412Aug 18 08:18 PM
Mirgorodskaya NataliaCorporate ControllerAug 12Option Exercise0.4316,0006,88038,259Aug 16 06:49 PM
Mirgorodskaya NataliaCorporate ControllerAug 12Sale167.6216,3512,740,75521,908Aug 16 06:49 PM
Gu PaulSVP, Product and Data ScienceJul 14Option Exercise2.1510,00021,500255,412Jul 15 04:10 PM
Gu PaulSVP, Product and Data ScienceJul 13Option Exercise2.1510,00021,500245,412Jul 14 04:40 PM
Gu PaulSVP, Product and Data ScienceMar 05Option Exercise2.1510,00021,500210,000Mar 09 04:12 PM
PZZA Papa John's International, Inc. daily Stock Chart
PZZA [NASD]
Papa John's International, Inc.
Index- P/E- EPS (ttm)-0.32 Insider Own1.00% Shs Outstand36.39M Perf Week-7.46%
Market Cap4.34B Forward P/E32.15 EPS next Y3.67 Insider Trans-66.50% Shs Float36.00M Perf Month-10.21%
Income-11.10M PEG- EPS next Q0.72 Inst Own99.70% Short Float4.06% Perf Quarter-3.46%
Sales2.01B P/S2.16 EPS this Y628.70% Inst Trans0.04% Short Ratio3.89 Perf Half Y7.68%
Book/sh-4.19 P/B- EPS next Y9.28% ROA1.10% Target Price145.94 Perf Year24.11%
Cash/sh2.88 P/C41.03 EPS next 5Y15.00% ROE-4.70% 52W Range78.41 - 140.68 Perf YTD-11.48%
Dividend1.40 P/FCF25.03 EPS past 5Y-7.50% ROI90.90% 52W High-16.02% Beta0.98
Dividend %1.18% Quick Ratio0.70 Sales past 5Y2.10% Gross Margin31.50% 52W Low50.68% ATR4.12
Employees16700 Current Ratio0.90 Sales Q/Q8.40% Oper. Margin8.80% RSI (14)34.16 Volatility3.63% 3.20%
OptionableYes Debt/Eq- EPS Q/Q127.00% Profit Margin0.50% Rel Volume1.12 Prev Close119.38
ShortableYes LT Debt/Eq- EarningsNov 04 BMO Payout351.40% Avg Volume376.22K Price118.15
Recom1.90 SMA20-8.59% SMA50-8.64% SMA2001.99% Volume421,700 Change-1.03%
Nov-12-21Initiated The Benchmark Company Buy $145
Nov-05-21Downgrade Northcoast Buy → Neutral $136
Nov-05-21Downgrade Deutsche Bank Buy → Hold $127 → $136
Oct-06-21Initiated Loop Capital Buy $147
Aug-06-21Reiterated UBS Neutral $114 → $121
Aug-06-21Reiterated Stifel Buy $125 → $140
Aug-06-21Reiterated Oppenheimer Outperform $135 → $140
Aug-06-21Reiterated KeyBanc Capital Markets Overweight $124 → $132
Aug-06-21Reiterated Deutsche Bank Buy $111 → $127
Jul-12-21Reiterated Stifel Buy $120 → $125
Mar-30-21Initiated BMO Capital Markets Outperform $105
Feb-22-21Reiterated Oppenheimer Outperform $110 → $125
Nov-10-20Upgrade Deutsche Bank Hold → Buy $89 → $91
Oct-30-20Upgrade Oppenheimer Perform → Outperform $96
Oct-02-20Initiated Loop Capital Buy $110
Oct-01-20Resumed KeyBanc Capital Markets Overweight $94
Jul-01-20Initiated Wedbush Outperform $95
May-29-20Upgrade Northcoast Neutral → Buy $93
May-01-20Downgrade Northcoast Buy → Neutral
Apr-27-20Downgrade MKM Partners Buy → Neutral $64 → $70
Jan-14-22 07:33AM  
Jan-13-22 01:43PM  
Jan-11-22 10:01AM  
08:36AM  
Jan-10-22 11:23AM  
10:12AM  
Jan-07-22 11:16AM  
10:37AM  
08:27AM  
06:00AM  
02:28AM  
Jan-05-22 07:32AM  
Dec-30-21 08:47AM  
08:41AM  
Dec-29-21 11:28AM  
09:06AM  
Dec-27-21 06:40AM  
Dec-23-21 08:07AM  
Dec-22-21 02:04PM  
09:23AM  
03:23AM  
Dec-21-21 11:25AM  
Dec-20-21 11:15AM  
10:13AM  
10:00AM  
09:00AM  
Dec-19-21 05:38AM  
Dec-17-21 02:50PM  
Dec-15-21 06:07AM  
Dec-11-21 06:38AM  
06:38AM  
Dec-09-21 02:14PM  
Dec-08-21 08:10AM  
Dec-07-21 04:38PM  
09:47AM  
08:52AM  
Dec-06-21 12:27PM  
08:52AM  
Dec-03-21 09:44AM  
09:42AM  
Dec-02-21 10:02AM  
Dec-01-21 08:55AM  
Nov-30-21 09:05AM  
Nov-25-21 08:46AM  
Nov-24-21 09:47AM  
09:45AM  
07:07AM  
Nov-23-21 12:20PM  
11:34AM  
09:30AM  
08:47AM  
05:42AM  
Nov-19-21 02:22PM  
Nov-17-21 10:55AM  
10:11AM  
10:05AM  
10:00AM  
Nov-16-21 08:59PM  
07:10PM  
12:04PM  
09:38AM  
09:35AM  
Nov-15-21 09:49AM  
Nov-12-21 09:00AM  
Nov-10-21 12:26PM  
Nov-08-21 09:24AM  
Nov-05-21 10:50AM  
08:08AM  
03:56AM  
Nov-04-21 12:30PM  
11:01AM  
10:32AM  
09:35AM  
07:00AM  
Oct-29-21 04:15PM  
12:10PM  
08:30AM  
Oct-28-21 03:05PM  
12:58PM  
Oct-27-21 09:39AM  
Oct-22-21 10:55AM  
Oct-18-21 09:00AM  
Oct-15-21 02:27PM  
08:00AM  
06:33AM  
Oct-14-21 09:10AM  
Oct-13-21 12:00PM  
Oct-08-21 10:00AM  
Sep-30-21 10:02AM  
Sep-29-21 01:00PM  
10:46AM  
07:51AM  
07:30AM  
07:01AM  
Sep-24-21 12:16PM  
Sep-22-21 09:42AM  
Sep-16-21 09:36AM  
Sep-14-21 04:30PM  
Sep-07-21 07:50AM  
Aug-25-21 08:01AM  
Papa John's International, Inc. operates and franchises pizza delivery and carryout restaurants under the Papa John's trademark in the United States and internationally. It operates through four segments: Domestic Company-Owned Restaurants, North America Commissaries, North America Franchising, and International Operations. The company also operates dine-in and delivery restaurants under the Papa John's trademark internationally. As of June 29, 2021, it operated 5,400 Papa John's restaurants, which included 588 company-owned and 4,812 franchised restaurants in 48 countries and territories. The company was founded in 1984 and is headquartered in Louisville, Kentucky.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIRTLEY OLIVIA FDirectorNov 29Option Exercise57.628,560493,24690,222Dec 01 05:03 PM
KIRTLEY OLIVIA FDirectorNov 29Sale128.263,850493,79886,372Dec 01 05:03 PM
Lynch RobertPresident and CEONov 24Sale133.4712,5001,668,38789,947Nov 26 08:18 PM
Swaysland Jack HCOO, InternationalNov 19Sale133.024,000532,0779,661Nov 23 05:58 PM
Smith Jeffrey CDirectorAug 19Sale112.00700,00078,400,000124,797Aug 20 07:00 AM
Norberg JamesCOO, North AmericaAug 12Option Exercise46.222,00092,4407,545Aug 13 04:47 PM
Norberg JamesCOO, North AmericaAug 12Sale125.002,000250,0005,545Aug 13 04:47 PM
Oyler Caroline MillerChief Legal & Risk OfficerAug 11Option Exercise50.593,708187,58829,024Aug 13 04:47 PM
Oyler Caroline MillerChief Legal & Risk OfficerAug 11Sale121.066,863830,83522,161Aug 13 04:47 PM
Swaysland Jack HCOO, InternationalJul 06Option Exercise53.167,246385,19720,907Jul 06 06:39 PM
Swaysland Jack HCOO, InternationalJul 06Sale104.157,246754,67113,661Jul 06 06:39 PM
Smith Jeffrey CDirectorMay 11Option Exercise50.063,458,360173,125,5021,567,209May 13 08:00 PM
EXEL Exelixis, Inc. daily Stock Chart
EXEL [NASD]
Exelixis, Inc.
Index- P/E35.53 EPS (ttm)0.51 Insider Own0.90% Shs Outstand315.38M Perf Week-3.31%
Market Cap5.62B Forward P/E22.48 EPS next Y0.81 Insider Trans-12.12% Shs Float309.90M Perf Month1.46%
Income164.30M PEG0.77 EPS next Q0.08 Inst Own85.30% Short Float3.80% Perf Quarter-16.96%
Sales1.25B P/S4.48 EPS this Y-65.50% Inst Trans-0.16% Short Ratio6.19 Perf Half Y11.17%
Book/sh6.70 P/B2.70 EPS next Y60.24% ROA7.20% Target Price29.62 Perf Year-23.62%
Cash/sh4.52 P/C4.01 EPS next 5Y46.00% ROE8.30% 52W Range15.50 - 25.77 Perf YTD-0.88%
Dividend- P/FCF20.45 EPS past 5Y19.70% ROI4.80% 52W High-29.69% Beta0.88
Dividend %- Quick Ratio6.10 Sales past 5Y92.70% Gross Margin96.10% 52W Low16.90% ATR0.65
Employees773 Current Ratio6.20 Sales Q/Q42.10% Oper. Margin15.50% RSI (14)48.61 Volatility3.71% 3.42%
OptionableYes Debt/Eq0.00 EPS Q/Q214.50% Profit Margin13.10% Rel Volume0.89 Prev Close17.77
ShortableYes LT Debt/Eq0.00 EarningsNov 02 AMC Payout0.00% Avg Volume1.90M Price18.12
Recom1.90 SMA20-2.28% SMA501.17% SMA200-10.47% Volume1,687,371 Change1.97%
Nov-19-21Initiated Piper Sandler Overweight $34
Nov-03-21Resumed Jefferies Buy $28
Oct-07-21Initiated Jefferies Buy $28
Aug-06-21Reiterated H.C. Wainwright Buy $35 → $64
Jun-15-21Initiated H.C. Wainwright Buy $47
May-18-21Resumed Goldman Sell $23
Mar-31-21Initiated Credit Suisse Outperform $30
Mar-12-21Initiated Wolfe Research Outperform $35
Mar-04-20Initiated Barclays Overweight $26
Jan-13-20Initiated SunTrust Buy $31
Nov-13-19Initiated BofA/Merrill Buy $22
Mar-18-19Upgrade Morgan Stanley Underweight → Equal-Weight
Sep-17-18Initiated Goldman Neutral $22
Sep-10-18Initiated Morgan Stanley Underweight $19
May-11-18Reiterated Needham Buy $33 → $30
Oct-17-17Reiterated RBC Capital Mkts Outperform $33 → $39
Oct-17-17Reiterated Needham Buy $30 → $33
Oct-16-17Reiterated SunTrust Buy $32 → $35
Sep-22-17Downgrade Leerink Partners Outperform → Mkt Perform
Sep-15-17Initiated RBC Capital Mkts Outperform $32
Jan-11-22 04:03AM  
Jan-10-22 04:24PM  
11:20AM  
Jan-09-22 04:00PM  
Jan-07-22 12:09PM  
Jan-06-22 09:38AM  
08:00AM  
Jan-05-22 08:00AM  
Jan-04-22 04:05PM  
08:00AM  
Jan-03-22 02:14PM  
Dec-26-21 07:41AM  
Dec-18-21 09:15AM  
Dec-17-21 08:00AM  
Dec-16-21 09:01AM  
02:38AM  
Dec-15-21 08:00AM  
07:32AM  
Dec-10-21 07:38AM  
06:00AM  
05:51AM  
Dec-07-21 11:38AM  
11:38AM  
Dec-02-21 11:31AM  
Nov-20-21 06:00AM  
Nov-18-21 10:27AM  
Nov-12-21 05:51AM  
Nov-09-21 08:00AM  
Nov-04-21 11:21AM  
09:25AM  
06:05AM  
Nov-03-21 04:05PM  
12:45PM  
11:40AM  
08:56AM  
Nov-02-21 11:01PM  
06:25PM  
04:05PM  
Nov-01-21 10:54AM  
Oct-30-21 06:00AM  
Oct-29-21 08:50AM  
Oct-28-21 10:00AM  
Oct-26-21 03:02PM  
10:43AM  
10:39AM  
Oct-19-21 04:05PM  
10:00AM  
Oct-18-21 12:21PM  
Oct-14-21 10:02AM  
08:00AM  
08:00AM  
Oct-13-21 05:51AM  
Sep-28-21 05:51AM  
Sep-22-21 08:36AM  
Sep-20-21 11:57AM  
11:30AM  
09:51AM  
Sep-18-21 07:30AM  
Sep-17-21 04:23PM  
Sep-16-21 07:49AM  
02:30AM  
Sep-11-21 11:45AM  
Sep-06-21 01:00PM  
Sep-02-21 06:19AM  
Sep-01-21 04:05PM  
Aug-26-21 07:51AM  
05:51AM  
Aug-25-21 04:05PM  
Aug-20-21 09:11AM  
Aug-18-21 11:47AM  
Aug-17-21 08:37AM  
Aug-16-21 03:47PM  
08:05AM  
Aug-06-21 11:29AM  
09:13AM  
12:01AM  
Aug-05-21 07:15PM  
04:05PM  
08:00AM  
Aug-02-21 05:51AM  
Jul-29-21 03:05PM  
Jul-26-21 05:51AM  
Jul-22-21 04:05PM  
08:06AM  
Jul-19-21 02:45AM  
Jul-16-21 05:51AM  
Jul-13-21 10:10AM  
Jul-09-21 07:41AM  
06:55AM  
Jul-08-21 04:05PM  
Jul-02-21 05:51AM  
Jun-30-21 04:04PM  
Jun-29-21 07:03PM  
Jun-28-21 04:15PM  
12:04PM  
01:00AM  
Jun-18-21 08:00AM  
05:51AM  
Jun-15-21 11:39AM  
Jun-14-21 08:00AM  
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. In addition, Exelixis, Inc. is developing XL092, an oral tyrosine kinase inhibitor that targets VEGF receptors, MET, AXL, MER, and other kinases implicated in growth and spread of cancer. Exelixis, Inc. has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; GlaxoSmithKline; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in Alameda, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lamb PeterEVP, Scientific Strategy & CSODec 15Option Exercise6.2147,500294,975410,672Dec 17 08:35 PM
Lamb PeterEVP, Scientific Strategy & CSODec 15Sale17.4447,500828,400363,172Dec 17 08:35 PM
Haley Patrick J.EVP, CommercialNov 24Sale17.2517,236297,321237,802Nov 26 07:39 PM
FELDBAUM CARL BDirectorNov 19Option Exercise3.1320,00062,60028,521Nov 23 08:11 PM
FELDBAUM CARL BDirectorNov 19Sale17.6220,000352,4008,521Nov 23 08:11 PM
Lamb PeterEVP, Scientific Strategy & CSONov 15Option Exercise6.2147,500294,975458,740Nov 17 08:02 PM
Lamb PeterEVP, Scientific Strategy & CSONov 15Sale18.0947,500859,275411,240Nov 17 08:02 PM
Hessekiel JeffreyEVP and General CounselNov 01Sale22.035,117112,728632,825Nov 03 08:12 PM
Lamb PeterEVP, Scientific Strategy & CSOOct 15Option Exercise6.2147,500294,975458,740Oct 15 08:15 PM
Lamb PeterEVP, Scientific Strategy & CSOOct 15Sale21.9247,5001,041,200411,240Oct 15 08:15 PM
Hessekiel JeffreyEVP and General CounselOct 15Sale22.0212,883283,684637,942Oct 15 08:14 PM
Senner Christopher J.EVP and CFOSep 21Option Exercise3.6690,000329,400446,591Sep 23 08:16 PM
Haley Patrick J.EVP, CommercialSep 16Option Exercise1.7025,00042,500305,994Sep 17 07:58 PM
Haley Patrick J.EVP, CommercialSep 16Sale20.3625,000509,000280,994Sep 17 07:58 PM
Lamb PeterEVP, Scientific Strategy & CSOSep 15Option Exercise6.2147,500294,975436,967Sep 17 07:56 PM
Lamb PeterEVP, Scientific Strategy & CSOSep 15Sale20.4647,500971,850389,467Sep 17 07:56 PM
Lamb PeterEVP, Scientific Strategy & CSOAug 16Option Exercise1.9055,000104,500444,467Aug 18 07:56 PM
Lamb PeterEVP, Scientific Strategy & CSOAug 16Sale18.4455,0001,014,200389,467Aug 18 07:56 PM
Schwab GiselaPres, Prod Dev & Med Aff & CMOJul 26Option Exercise4.2040,000168,000689,078Jul 28 08:06 PM
Schwab GiselaPres, Prod Dev & Med Aff & CMOJul 21Option Exercise4.2035,000147,000649,078Jul 23 07:47 PM
Lamb PeterEVP, Scientific Strategy & CSOJul 15Option Exercise1.9060,000114,000449,467Jul 16 07:58 PM
Lamb PeterEVP, Scientific Strategy & CSOJul 15Sale17.4760,0001,048,200389,467Jul 16 07:58 PM
COHEN CHARLESDirectorJul 06Option Exercise4.7180,000377,200261,375Jul 08 07:45 PM
Lamb PeterEVP, Scientific Strategy & CSOJun 17Option Exercise1.9060,000114,000449,467Jun 22 08:03 PM
Lamb PeterEVP, Scientific Strategy & CSOJun 17Sale22.1860,0001,330,800389,467Jun 22 08:03 PM
Haley Patrick J.EVP, CommercialMay 18Sale24.7314,593360,885280,994May 18 08:13 PM
MARCHESI VINCENT TDirectorMay 14Option Exercise6.3040,000252,000106,115May 17 08:13 PM
MARCHESI VINCENT TDirectorMay 14Sale25.0440,0001,001,60066,115May 17 08:13 PM
POSTE GEORGEDirectorMay 14Sale24.9740,8021,018,826157,190May 17 08:11 PM
Schwab GiselaPres, Prod Dev & Med Aff & CMOMay 13Option Exercise1.90100,000190,000714,078May 14 08:35 PM
Schwab GiselaPres, Prod Dev & Med Aff & CMOMay 13Sale25.38100,0002,538,000614,078May 14 08:35 PM
MORRISSEY MICHAELPresident and CEOMay 12Option Exercise4.2050,000210,000541,813May 14 08:51 PM
PAPADOPOULOS STELIOSDirectorMay 11Option Exercise4.27120,000512,4001,293,600May 13 08:32 PM
PAPADOPOULOS STELIOSDirectorMay 11Sale24.9820,770518,7941,218,675May 13 08:32 PM
Freire Maria CDirectorMay 11Sale25.018,275206,95831,827May 17 08:15 PM
Schwab GiselaPres, Prod Dev & Med Aff & CMOApr 26Option Exercise1.7050,00085,000663,482Apr 28 08:10 PM
Schwab GiselaPres, Prod Dev & Med Aff & CMOApr 26Sale25.0050,0001,250,000613,482Apr 28 08:10 PM
Haley Patrick J.EVP, CommercialApr 26Sale25.037,665191,855297,392Apr 28 08:08 PM
Hessekiel JeffreyEVP and General CounselApr 26Sale25.0318,000450,540628,248Apr 28 08:06 PM
Schwab GiselaPres, Prod Dev & Med Aff & CMOApr 01Option Exercise1.7050,00085,000663,482Apr 02 07:41 PM
Lamb PeterEVP, Scientific Strategy & CSOApr 01Option Exercise1.7060,000102,000449,467Apr 02 07:51 PM
Lamb PeterEVP, Scientific Strategy & CSOApr 01Sale22.9660,0001,377,600389,467Apr 02 07:51 PM
Schwab GiselaPres, Prod Dev & Med Aff & CMOApr 01Sale23.0050,0001,150,000613,482Apr 02 07:41 PM
WYSZOMIERSKI JACK LDirectorMar 29Option Exercise3.3840,000135,200237,809Mar 31 09:02 PM
WYSZOMIERSKI JACK LDirectorMar 29Sale22.646,220140,821231,589Mar 31 09:02 PM
Garber Alan MDirectorMar 15Option Exercise3.3840,000135,20052,718Mar 17 08:11 PM
Garber Alan MDirectorMar 15Sale23.6040,000944,00012,718Mar 17 08:11 PM
Lamb PeterEVP, Scientific Strategy & CSOMar 01Option Exercise1.7065,000110,500405,072Mar 03 07:49 PM
Lamb PeterEVP, Scientific Strategy & CSOMar 01Sale22.1165,0001,437,150340,072Mar 03 07:49 PM
COHEN CHARLESDirectorFeb 24Option Exercise3.3840,000135,200221,375Feb 26 08:10 PM
COHEN CHARLESDirectorFeb 24Sale22.6940,000907,600181,375Feb 26 08:10 PM
WILLSEY LANCEDirectorFeb 23Option Exercise3.3840,000135,200464,415Feb 24 08:11 PM
WILLSEY LANCEDirectorFeb 23Sale21.9340,000877,136424,415Feb 24 08:11 PM
POSTE GEORGEDirectorFeb 22Option Exercise3.3840,000135,200197,992Feb 24 08:18 PM
MARCHESI VINCENT TDirectorFeb 22Sale22.2924,097537,12266,115Feb 24 08:15 PM
Schwab GiselaPres, Prod Dev & Med Aff & CMOFeb 18Option Exercise1.7050,00085,000590,597Feb 19 07:57 PM
Schwab GiselaPres, Prod Dev & Med Aff & CMOFeb 18Sale22.3550,0001,117,500540,597Feb 19 07:57 PM
Schwab GiselaPres, Prod Dev & Med Aff & CMOFeb 17Option Exercise1.7050,00085,000590,597Feb 19 07:57 PM
Schwab GiselaPres, Prod Dev & Med Aff & CMOFeb 17Sale22.5050,0001,125,000540,597Feb 19 07:57 PM
FELDBAUM CARL BDirectorFeb 16Option Exercise3.3820,00067,60028,521Feb 17 08:03 PM
FELDBAUM CARL BDirectorFeb 16Sale21.9620,000439,2008,521Feb 17 08:03 PM
WILLSEY LANCEDirectorFeb 16Sale21.9050,0001,095,000424,415Feb 24 08:11 PM
Haley Patrick J.EVP, CommercialFeb 12Sale21.5745,000970,650246,887Feb 17 08:15 PM
Lamb PeterEVP, Scientific Strategy & CSOFeb 01Option Exercise1.7065,000110,500348,124Feb 03 07:57 PM
Lamb PeterEVP, Scientific Strategy & CSOFeb 01Sale22.0865,0001,435,200283,124Feb 03 07:57 PM
ANET Arista Networks, Inc. daily Stock Chart
ANET [NYSE]
Arista Networks, Inc.
IndexS&P 500 P/E52.70 EPS (ttm)2.46 Insider Own0.10% Shs Outstand307.46M Perf Week0.20%
Market Cap40.32B Forward P/E37.45 EPS next Y3.46 Insider Trans-89.29% Shs Float225.42M Perf Month-6.43%
Income784.50M PEG2.88 EPS next Q0.73 Inst Own65.50% Short Float1.77% Perf Quarter33.14%
Sales2.77B P/S14.54 EPS this Y-24.90% Inst Trans-0.15% Short Ratio1.76 Perf Half Y43.31%
Book/sh12.57 P/B10.32 EPS next Y24.78% ROA15.50% Target Price138.21 Perf Year63.67%
Cash/sh10.90 P/C11.90 EPS next 5Y18.27% ROE21.90% 52W Range65.52 - 148.57 Perf YTD-9.75%
Dividend- P/FCF44.09 EPS past 5Y36.70% ROI17.90% 52W High-12.67% Beta1.22
Dividend %- Quick Ratio4.40 Sales past 5Y22.60% Gross Margin63.90% 52W Low98.02% ATR4.26
Employees2613 Current Ratio5.10 Sales Q/Q23.70% Oper. Margin30.80% RSI (14)43.49 Volatility3.03% 3.33%
OptionableYes Debt/Eq0.00 EPS Q/Q32.20% Profit Margin28.30% Rel Volume0.85 Prev Close131.20
ShortableYes LT Debt/Eq0.00 EarningsNov 01 AMC Payout0.00% Avg Volume2.27M Price129.74
Recom2.30 SMA20-5.59% SMA50-1.91% SMA20029.92% Volume1,939,929 Change-1.11%
Dec-17-21Upgrade Cleveland Research Neutral → Buy
Nov-19-21Downgrade Morgan Stanley Overweight → Equal-Weight $115 → $138
Nov-16-21Downgrade UBS Buy → Neutral $490 → $530
Nov-02-21Reiterated Wells Fargo Equal Weight $375 → $490
Nov-02-21Reiterated Morgan Stanley Overweight $420 → $460
Nov-02-21Reiterated JMP Securities Mkt Outperform $415 → $540
Nov-02-21Reiterated Evercore ISI Outperform $480 → $520
Nov-02-21Reiterated Credit Suisse Outperform $410 → $509
Nov-02-21Reiterated Barclays Equal Weight $378 → $451
Apr-23-21Resumed KeyBanc Capital Markets Overweight $365
Jan-07-21Upgrade Rosenblatt Neutral → Buy $335
Jan-06-21Upgrade Credit Suisse Neutral → Outperform $351
Dec-16-20Upgrade Wolfe Research Peer Perform → Outperform $250 → $350
Nov-18-20Upgrade Evercore ISI In-line → Outperform $250 → $310
Nov-03-20Upgrade BofA Securities Neutral → Buy $270
Oct-30-20Upgrade Morgan Stanley Equal-Weight → Overweight $250
Oct-30-20Upgrade MKM Partners Neutral → Buy $225
Oct-12-20Downgrade Citigroup Buy → Neutral $290 → $230
Oct-08-20Upgrade JP Morgan Neutral → Overweight $275
Sep-23-20Resumed UBS Buy $260
Jan-16-22 06:17AM  
Jan-11-22 10:46AM  
Jan-10-22 06:00PM  
09:41AM  
Jan-07-22 05:38PM  
12:33PM  
08:17AM  
Jan-06-22 08:41AM  
Jan-05-22 07:07AM  
Jan-03-22 06:00PM  
Dec-31-21 09:56AM  
Dec-24-21 04:33AM  
Dec-23-21 10:00AM  
09:52AM  
Dec-22-21 09:53AM  
Dec-21-21 09:39AM  
06:39AM  
Dec-20-21 09:46AM  
Dec-16-21 08:14AM  
Dec-15-21 02:38AM  
Dec-14-21 09:34AM  
Dec-13-21 04:36PM  
Dec-11-21 08:00AM  
05:38AM  
Dec-10-21 02:18PM  
01:01PM  
08:20AM  
Dec-09-21 09:15AM  
Dec-08-21 03:06PM  
01:04PM  
11:09AM  
Dec-06-21 12:53PM  
Dec-01-21 11:30AM  
Nov-30-21 10:06AM  
04:40AM  
Nov-22-21 11:09AM  
09:43AM  
Nov-19-21 03:47PM  
08:07AM  
Nov-18-21 10:05AM  
03:49AM  
Nov-17-21 09:35AM  
09:16AM  
09:12AM  
09:07AM  
08:49AM  
Nov-16-21 09:00AM  
Nov-12-21 08:21AM  
Nov-11-21 09:00AM  
Nov-10-21 09:21AM  
Nov-09-21 12:30PM  
07:53AM  
Nov-08-21 08:17AM  
Nov-04-21 08:22AM  
Nov-03-21 02:00PM  
11:17AM  
Nov-02-21 05:55PM  
04:36PM  
04:09PM  
12:06PM  
11:36AM  
11:08AM  
08:54AM  
08:26AM  
07:52AM  
07:04AM  
06:00AM  
04:08AM  
Nov-01-21 11:30PM  
05:45PM  
05:37PM  
04:18PM  
04:05PM  
Oct-31-21 08:15AM  
Oct-30-21 02:33PM  
Oct-29-21 09:15AM  
Oct-26-21 07:39PM  
01:58PM  
07:56AM  
Oct-25-21 03:01PM  
Oct-21-21 07:25AM  
Oct-18-21 05:23AM  
Oct-12-21 02:01PM  
11:12AM  
Oct-11-21 12:34PM  
Oct-07-21 08:00AM  
Oct-06-21 11:35AM  
09:00AM  
Oct-04-21 04:00PM  
Oct-01-21 08:49AM  
Sep-20-21 09:36AM  
Sep-08-21 09:05AM  
Sep-07-21 07:30PM  
Sep-04-21 09:28PM  
Sep-01-21 11:30AM  
07:44AM  
Aug-25-21 09:11AM  
Aug-24-21 09:00AM  
Aug-06-21 08:05AM  
Aug-05-21 05:21PM  
Arista Networks, Inc. develops, markets, and sells cloud networking solutions in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company's cloud networking solutions consist of extensible operating systems, a set of network applications, as well as gigabit Ethernet switching and routing platforms. It also provides post contract customer support services, such as technical support, hardware repair and parts replacement beyond standard warranty, bug fix, patch, and upgrade services. The company serves a range of industries comprising internet companies, service providers, financial services organizations, government agencies, media and entertainment companies, and others. It markets and sells its products through distributors, value-added resellers, system integrators, and original equipment manufacturer partners, as well as through its direct sales force. The company was formerly known as Arastra, Inc. and changed its name to Arista Networks, Inc. in October 2008. Arista Networks, Inc. was incorporated in 2004 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Duda KennethCTO and SVP Software Eng.Jan 10Option Exercise1.9440,00077,60060,117Jan 12 07:08 PM
Duda KennethCTO and SVP Software Eng.Jan 10Sale127.9740,0005,118,80720,117Jan 12 07:08 PM
Duda KennethCTO and SVP Software Eng.Jan 10Sale127.8918,1362,319,36219,888Jan 12 07:08 PM
McCool John FChief Platform OfficerJan 03Option Exercise52.691,32869,9761,328Jan 05 07:29 PM
Taxay MarcSVP and General CounselJan 03Option Exercise57.8217,7481,026,25417,748Jan 05 07:29 PM
Sadana AnshulSVP, Chief Operating OfficerJan 03Option Exercise19.9510,672212,85526,789Jan 05 07:29 PM
McCool John FChief Platform OfficerJan 03Sale144.091,328191,3520Jan 05 07:29 PM
Giancarlo Charles HDirectorJan 03Sale142.486,660948,908145,566Jan 05 07:29 PM
Taxay MarcSVP and General CounselJan 03Sale142.5517,7482,530,0500Jan 05 07:29 PM
Sadana AnshulSVP, Chief Operating OfficerJan 03Sale142.4610,6721,520,30916,117Jan 05 07:29 PM
Duda KennethCTO and SVP Software Eng.Dec 10Option Exercise1.9440,00077,60060,117Dec 14 08:46 PM
Duda KennethCTO and SVP Software Eng.Dec 10Sale130.0040,0005,199,96820,117Dec 14 08:46 PM
Duda KennethCTO and SVP Software Eng.Dec 10Sale130.0018,1362,357,64436,224Dec 14 08:46 PM
BECHTOLSHEIM ANDREASChief Development OfficerDec 06Option Exercise21.3615,000320,428103,429Dec 08 08:45 PM
BECHTOLSHEIM ANDREASChief Development OfficerDec 06Sale121.0215,0001,815,30888,429Dec 08 08:45 PM
BECHTOLSHEIM ANDREASChief Development OfficerDec 02Sale122.31100,00012,230,53547,920,000Dec 03 07:07 PM
Brennan Ita MSenior Vice President, CFODec 01Option Exercise14.0614,800208,08840,631Dec 03 07:08 PM
Taxay MarcSVP and General CounselDec 01Option Exercise15.752,00431,5706,354Dec 03 07:09 PM
Sadana AnshulSVP, Chief Operating OfficerDec 01Option Exercise17.7316,936300,22533,053Dec 03 07:08 PM
McCool John FChief Platform OfficerDec 01Option Exercise52.661,33670,3531,336Dec 03 07:08 PM
Giancarlo Charles HDirectorDec 01Sale124.386,660828,369186,616Dec 03 07:08 PM
Brennan Ita MSenior Vice President, CFODec 01Sale124.3614,8001,840,52225,831Dec 03 07:08 PM
Taxay MarcSVP and General CounselDec 01Sale124.076,354788,3650Dec 03 07:09 PM
Sadana AnshulSVP, Chief Operating OfficerDec 01Sale124.3616,9362,106,16416,117Dec 03 07:08 PM
McCool John FChief Platform OfficerDec 01Sale125.131,336167,1740Dec 03 07:08 PM
BECHTOLSHEIM ANDREASChief Development OfficerDec 01Sale124.09100,00012,409,25548,020,000Dec 02 06:26 PM
BECHTOLSHEIM ANDREASChief Development OfficerNov 30Sale124.60100,00012,459,84148,120,000Dec 02 06:26 PM
BECHTOLSHEIM ANDREASChief Development OfficerNov 29Sale126.51100,00012,651,35748,220,000Nov 30 07:22 PM
BECHTOLSHEIM ANDREASChief Development OfficerNov 26Sale125.11100,00012,511,29848,320,000Nov 30 07:22 PM
Sadana AnshulSVP, Chief Operating OfficerNov 26Sale125.187,385924,44916,117Nov 30 07:22 PM
McCool John FChief Platform OfficerNov 24Sale127.256,783863,1310Nov 26 07:08 PM
BECHTOLSHEIM ANDREASChief Development OfficerNov 24Sale127.33100,00012,733,23048,420,000Nov 26 07:08 PM
Battles Kelly BodnarDirectorNov 24Sale127.431,120142,7161,944Nov 26 07:07 PM
BECHTOLSHEIM ANDREASChief Development OfficerNov 23Option Exercise37.2611,668434,716100,097Nov 26 07:08 PM
BECHTOLSHEIM ANDREASChief Development OfficerNov 23Sale125.6911,6681,466,51188,429Nov 26 07:08 PM
BECHTOLSHEIM ANDREASChief Development OfficerNov 23Sale125.66100,00012,565,65148,520,000Nov 26 07:08 PM
CHEW LEWISDirectorNov 22Option Exercise0.0061601,232Nov 24 06:49 PM
Brennan Ita MSenior Vice President, CFONov 22Option Exercise0.009,720030,652Nov 24 06:49 PM
BECHTOLSHEIM ANDREASChief Development OfficerNov 22Option Exercise10.24113,2521,159,861188,429Nov 24 06:49 PM
Battles Kelly BodnarDirectorNov 22Option Exercise0.0069203,064Nov 24 06:48 PM
Sadana AnshulSVP, Chief Operating OfficerNov 22Option Exercise0.0020,708033,772Nov 24 06:50 PM
McCool John FChief Platform OfficerNov 22Option Exercise0.0013,456013,456Nov 24 06:50 PM
MATHER ANNDirectorNov 22Option Exercise0.0087603,220Nov 24 06:50 PM
Giancarlo Charles HDirectorNov 22Option Exercise0.00876048,776Nov 24 06:49 PM
Duda KennethCTO and SVP Software Eng.Nov 22Option Exercise0.0011,168025,656Nov 24 06:49 PM
Ullal JayshreePresident and CEONov 22Option Exercise0.0014,296024,132Nov 24 06:51 PM
Theodosopoulos NikosDirectorNov 22Option Exercise0.00692022,572Nov 24 06:51 PM
TEMPLETON MARK BDirectorNov 22Option Exercise0.00692026,532Nov 24 06:51 PM
Taxay MarcSVP and General CounselNov 22Option Exercise0.008,63208,632Nov 24 06:51 PM
Scheinman DanielDirectorNov 22Option Exercise0.00876037,444Nov 24 06:50 PM
BECHTOLSHEIM ANDREASChief Development OfficerNov 22Sale129.55100,00012,954,99888,429Nov 24 06:49 PM
BECHTOLSHEIM ANDREASChief Development OfficerNov 22Sale129.55100,00012,954,57048,620,000Nov 24 06:49 PM
MATHER ANNDirectorNov 22Sale130.13876113,9942,344Nov 24 06:50 PM
Ullal JayshreePresident and CEONov 22Sale130.13100,00013,013,0001,783,200Nov 24 06:51 PM
Ullal JayshreePresident and CEONov 19Sale129.51100,00012,951,0001,803,200Nov 22 09:42 PM
Ullal JayshreePresident and CEONov 18Sale130.00100,00013,000,0001,823,200Nov 22 09:42 PM
Ullal JayshreePresident and CEONov 17Sale521.0025,00013,025,000460,800Nov 18 04:09 PM
Ullal JayshreePresident and CEONov 16Sale518.0025,00012,950,000465,800Nov 18 04:09 PM
Ullal JayshreePresident and CEONov 15Sale525.0020,00010,500,000470,800Nov 15 07:20 PM
Ullal JayshreePresident and CEONov 12Sale519.0024,00012,456,000474,800Nov 15 07:20 PM
Ullal JayshreePresident and CEONov 11Sale523.6624,00012,567,840479,300Nov 15 07:20 PM
Duda KennethCTO and SVP Software Eng.Nov 10Option Exercise7.7610,00077,60013,622Nov 12 09:27 PM
Duda KennethCTO and SVP Software Eng.Nov 10Sale525.4010,0005,254,0383,622Nov 12 09:27 PM
Duda KennethCTO and SVP Software Eng.Nov 10Sale528.934,4282,342,09413,140Nov 12 09:27 PM
Ullal JayshreePresident and CEONov 10Sale523.8824,00012,573,120483,800Nov 12 09:27 PM
Duda KennethCTO and SVP Software Eng.Nov 10Sale533.4110656,54257,000Nov 12 09:27 PM
Ullal JayshreePresident and CEONov 09Sale527.4524,00012,658,800488,300Nov 12 09:27 PM
Ullal JayshreePresident and CEONov 08Sale530.5024,00012,732,000492,800Nov 08 09:18 PM
Ullal JayshreePresident and CEONov 05Sale521.0023,00011,983,000497,300Nov 08 09:18 PM
McCool John FChief Platform OfficerNov 04Option Exercise227.234,041918,2396,041Nov 08 09:42 PM
Ullal JayshreePresident and CEONov 04Sale496.0323,00011,408,690501,800Nov 05 08:03 PM
McCool John FChief Platform OfficerNov 04Sale505.016,0413,050,7720Nov 08 09:42 PM
Ullal JayshreePresident and CEONov 03Sale491.0323,00011,293,690506,300Nov 05 08:03 PM
Ullal JayshreePresident and CEONov 02Sale495.0026,00012,870,0003,000Nov 03 06:17 PM
Sadana AnshulSVP, Chief Operating OfficerNov 01Option Exercise70.844,232299,7807,498Nov 03 06:17 PM
MATHER ANNDirectorNov 01Option Exercise30.6741612,7591,002Nov 03 06:17 PM
Taxay MarcSVP and General CounselNov 01Option Exercise63.0149831,381498Nov 03 06:17 PM
Sadana AnshulSVP, Chief Operating OfficerNov 01Sale410.994,2321,739,3193,266Nov 03 06:17 PM
MATHER ANNDirectorNov 01Sale408.58416169,969586Nov 03 06:17 PM
Giancarlo Charles HDirectorNov 01Sale410.761,665683,90948,319Nov 03 06:16 PM
Ullal JayshreePresident and CEONov 01Sale408.5821,5008,784,470515,300Nov 03 06:17 PM
Taxay MarcSVP and General CounselNov 01Sale408.58498203,4730Nov 03 06:17 PM
Ullal JayshreePresident and CEOOct 29Sale404.4421,0008,493,240519,800Nov 01 08:26 PM
Ullal JayshreePresident and CEOOct 28Sale403.4920,0008,069,800524,300Nov 01 08:26 PM
Ullal JayshreePresident and CEOOct 27Sale400.2418,4007,364,416528,800Oct 28 08:08 PM
Brennan Ita MSenior Vice President, CFOOct 26Option Exercise74.8417,7841,330,94723,017Oct 28 08:07 PM
Ullal JayshreePresident and CEOOct 26Sale397.1717,5006,950,475533,000Oct 28 08:08 PM
Brennan Ita MSenior Vice President, CFOOct 26Sale403.9817,7847,184,3155,233Oct 28 08:07 PM
Ullal JayshreePresident and CEOOct 18Sale393.9317,0006,696,810537,000Oct 19 08:07 PM
Ullal JayshreePresident and CEOOct 15Sale394.8816,5006,515,520541,000Oct 19 08:07 PM
Ullal JayshreePresident and CEOOct 14Sale385.0016,0006,160,000545,000Oct 15 06:35 PM
Ullal JayshreePresident and CEOOct 13Sale381.8113,5005,154,435549,000Oct 15 06:35 PM
Duda KennethCTO and SVP Software Eng.Oct 11Option Exercise7.7610,00077,60013,622Oct 13 08:42 PM
Duda KennethCTO and SVP Software Eng.Oct 11Sale376.6110,0003,766,1193,622Oct 13 08:42 PM
Duda KennethCTO and SVP Software Eng.Oct 11Sale375.664,5341,703,24917,224Oct 13 08:42 PM
Sadana AnshulSVP, Chief Operating OfficerOct 07Option Exercise70.914,234300,2257,500Oct 12 08:47 PM
Sadana AnshulSVP, Chief Operating OfficerOct 07Sale360.394,2341,525,8923,266Oct 12 08:47 PM
MATHER ANNDirectorOct 01Option Exercise30.6741712,7891,003Oct 05 07:37 PM
Taxay MarcSVP and General CounselOct 01Option Exercise63.0150131,570501Oct 05 07:37 PM
MATHER ANNDirectorOct 01Sale345.00417143,865586Oct 05 07:37 PM
GDOT Green Dot Corporation daily Stock Chart
GDOT [NYSE]
Green Dot Corporation
Index- P/E58.40 EPS (ttm)0.59 Insider Own2.10% Shs Outstand54.22M Perf Week-3.89%
Market Cap1.92B Forward P/E12.85 EPS next Y2.69 Insider Trans-37.08% Shs Float53.97M Perf Month-2.09%
Income33.80M PEG3.89 EPS next Q0.31 Inst Own96.80% Short Float5.18% Perf Quarter-23.44%
Sales1.39B P/S1.38 EPS this Y-77.40% Inst Trans0.07% Short Ratio6.38 Perf Half Y-23.22%
Book/sh19.95 P/B1.74 EPS next Y19.88% ROA1.90% Target Price55.00 Perf Year-35.89%
Cash/sh- P/C- EPS next 5Y15.00% ROE7.90% 52W Range33.26 - 58.00 Perf YTD-4.44%
Dividend- P/FCF10.80 EPS past 5Y-10.00% ROI0.70% 52W High-40.29% Beta0.90
Dividend %- Quick Ratio0.70 Sales past 5Y12.50% Gross Margin- 52W Low4.13% ATR1.14
Employees1200 Current Ratio0.70 Sales Q/Q16.60% Oper. Margin7.80% RSI (14)37.83 Volatility3.76% 3.06%
OptionableYes Debt/Eq2.74 EPS Q/Q334.40% Profit Margin6.00% Rel Volume0.52 Prev Close35.10
ShortableYes LT Debt/Eq0.00 EarningsNov 04 AMC Payout0.00% Avg Volume438.05K Price34.63
Recom2.30 SMA20-2.98% SMA50-8.75% SMA200-21.52% Volume227,907 Change-1.34%
Jan-14-21Downgrade Northland Capital Outperform → Market Perform
Oct-08-20Reiterated Needham Buy $62 → $70
May-12-20Reiterated Needham Buy $30 → $40
Mar-26-20Upgrade BTIG Research Neutral → Buy $35
Mar-19-20Upgrade Northland Capital Market Perform → Outperform $35
Feb-14-20Downgrade Northland Capital Outperform → Market Perform
Feb-04-20Upgrade Citigroup Sell → Neutral $22 → $34
Dec-19-19Downgrade Citigroup Neutral → Sell $27 → $21
Nov-11-19Downgrade Guggenheim Buy → Neutral
Oct-11-19Upgrade Northland Capital Market Perform → Outperform
Sep-12-19Initiated Canaccord Genuity Hold $29
Sep-12-19Initiated Canaccord Genuity Hold
Sep-05-19Downgrade Jefferies Buy → Hold $62 → $32
Aug-09-19Upgrade Guggenheim Neutral → Buy
Aug-08-19Downgrade Keefe Bruyette Outperform → Mkt Perform $60 → $35
May-09-19Reiterated Needham Buy $75 → $60
May-09-19Downgrade Northland Capital Outperform → Market Perform
May-09-19Downgrade Guggenheim Buy → Neutral
May-09-19Downgrade Citigroup Buy → Neutral
May-09-19Downgrade BTIG Research Buy → Neutral
Jan-14-22 12:40PM  
Dec-15-21 05:38PM  
11:18AM  
Dec-12-21 10:42PM  
Nov-23-21 05:08AM  
Nov-16-21 09:43AM  
Nov-08-21 08:44AM  
Nov-04-21 09:32PM  
08:56PM  
04:05PM  
09:49AM  
Oct-28-21 03:06PM  
Oct-26-21 08:00AM  
Oct-25-21 12:31PM  
Oct-13-21 04:30PM  
Sep-21-21 11:00AM  
Sep-20-21 04:57PM  
Sep-17-21 11:49AM  
Sep-14-21 11:28AM  
Sep-10-21 10:26AM  
Sep-07-21 10:03AM  
Sep-02-21 11:31AM  
08:00AM  
Aug-31-21 11:38AM  
10:16AM  
Aug-30-21 05:02AM  
Aug-26-21 08:00AM  
Aug-17-21 08:00AM  
Aug-06-21 11:24AM  
Aug-04-21 01:31AM  
Aug-03-21 05:35PM  
04:05PM  
Jul-27-21 03:03PM  
Jul-21-21 11:12AM  
11:00AM  
Jul-19-21 07:26PM  
Jul-13-21 08:38AM  
Jul-08-21 02:00PM  
01:02PM  
12:10PM  
Jun-25-21 09:53AM  
Jun-24-21 12:00PM  
Jun-10-21 02:12PM  
Jun-08-21 10:15AM  
Jun-04-21 11:31AM  
May-21-21 04:44PM  
03:02PM  
May-11-21 09:35AM  
May-10-21 01:23PM  
May-08-21 03:48AM  
May-06-21 01:01AM  
May-05-21 08:05PM  
04:30PM  
May-04-21 03:24AM  
Apr-28-21 12:34PM  
Apr-26-21 04:15PM  
Apr-18-21 10:48PM  
Apr-17-21 12:15PM  
Mar-24-21 11:30AM  
06:17AM  
Mar-16-21 11:54AM  
11:02AM  
Mar-03-21 06:47AM  
Feb-23-21 04:00AM  
Feb-22-21 04:17PM  
08:00AM  
Feb-19-21 10:28AM  
Feb-10-21 12:31PM  
Feb-09-21 06:37PM  
Feb-04-21 08:00AM  
Feb-03-21 10:09AM  
Jan-26-21 10:20AM  
Jan-24-21 06:13AM  
Jan-21-21 12:41PM  
Jan-12-21 08:42AM  
Jan-07-21 08:55AM  
Jan-06-21 02:24PM  
12:06PM  
06:00AM  
Dec-30-20 08:44AM  
Dec-23-20 08:45AM  
Dec-04-20 11:31AM  
Dec-02-20 02:01PM  
Nov-19-20 07:00AM  
Nov-18-20 07:41AM  
Nov-11-20 09:49AM  
Nov-05-20 08:26AM  
Nov-04-20 11:02PM  
06:05PM  
05:42PM  
04:05PM  
Oct-28-20 01:28PM  
12:32PM  
Oct-27-20 07:00AM  
Oct-26-20 12:10PM  
08:46AM  
Oct-23-20 10:11AM  
Oct-22-20 06:27PM  
Oct-21-20 12:10PM  
Oct-20-20 10:45AM  
Green Dot Corporation operates as a financial technology and bank holding company in the United States. It operates in two segments, Account Services, and Processing and Settlement Services. The company offers deposit account programs, such network-branded reloadable prepaid debit cards under the consumer brand names of General Purpose Reloadable cards, consumer and small business checking accounts, network-branded gift cards, secured credit cards, and payroll debit cards. It also provides money processing services, including cash transfer services that help consumers to add funds directly to an account at the point-of-sale at any participating retailer; and simply paid disbursement services that enable wages and authorized funds disbursement to deposit account programs and accounts issued by any third-party bank or program manager. In addition, the company offers tax processing services that include tax refund transfers, which provide the processing technology to facilitate receipt of a taxpayers' refund proceeds; small business lending to independent tax preparation providers that seek small advances; and fast cash advance, a consumer-friendly loan that enables tax refund recipients. It markets its products under the Green Dot, GoBank, MoneyPak, TPG, and other brands. Green Dot Corporation markets and sells its products and services through retail stores; mobile applications; and various direct-to-consumer channels, such as online search engine optimization, online displays, direct mail campaigns, mobile advertising, and affiliate referral programs, as well as distributes through A'Banking as a Service' platform. The company was formerly known as Next Estate Communications, Inc. and changed its name to Green Dot Corporation in October 2005. Green Dot Corporation was incorporated in 1999 and is based in Pasadena, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JACOBS WILLIAM IDirectorDec 15Sale35.2450017,62065,615Dec 17 05:40 PM
Osher JeffreyDirectorNov 23Sale38.22670,00025,607,4000Nov 26 06:37 PM
JACOBS WILLIAM IDirectorNov 15Sale43.7350021,86566,115Nov 17 05:03 PM
Date Rajeev VDirectorNov 09Sale44.536,276279,48017,214Nov 10 05:46 PM
JACOBS WILLIAM IDirectorOct 15Sale46.0750023,03566,615Oct 19 06:21 PM
JACOBS WILLIAM IDirectorSep 15Sale48.6050024,30067,115Sep 17 06:04 PM
Unruh JessCAO/Operational CFOSep 07Sale54.053,318179,35472,724Sep 09 05:43 PM
JACOBS WILLIAM IDirectorAug 16Sale45.7750022,88567,615Aug 18 05:05 PM
Unruh JessCAO/Operational CFOAug 03Sale44.023,317145,99876,042Aug 05 08:03 PM
JACOBS WILLIAM IDirectorJul 15Sale45.4550022,72568,115Jul 16 05:28 PM
Unruh JessCAO/Operational CFOJul 06Sale46.243,317153,36679,359Jul 08 06:46 PM
JACOBS WILLIAM IDirectorJun 15Sale47.0750023,53568,615Jun 17 05:38 PM
Unruh JessCAO/Operational CFOJun 01Sale40.203,317133,35082,676Jun 03 05:03 PM
JACOBS WILLIAM IDirectorMay 17Sale40.1150020,05562,901May 19 05:54 PM
Unruh JessCAO/Operational CFOMay 04Sale44.863,317148,81585,993May 06 06:21 PM
JACOBS WILLIAM IDirectorApr 15Sale45.8250022,91063,401Apr 19 05:04 PM
Unruh JessCAO/Operational CFOApr 05Sale47.509,911470,79089,310Apr 07 06:10 PM
JACOBS WILLIAM IDirectorMar 15Sale51.3850025,69063,901Mar 17 05:58 PM
Lockwood Kristina SGeneral Counsel and SecretaryMar 12Sale51.3630115,45820,703Mar 15 05:22 PM
Osher JeffreyDirectorMar 05Sale45.6072,9803,328,182104,010Mar 09 06:12 PM
Osher JeffreyDirectorMar 04Sale45.4420,000908,808692,980Mar 05 07:20 PM
Osher JeffreyDirectorMar 03Sale47.742,526120,591712,980Mar 05 07:20 PM
Osher JeffreyDirectorMar 02Sale47.664,336206,649715,506Mar 02 08:02 PM
Osher JeffreyDirectorMar 01Sale49.04149,7827,345,994108,040Mar 02 08:02 PM
Osher JeffreyDirectorFeb 26Sale47.6328,6851,366,267852,508Mar 02 08:02 PM
Osher JeffreyDirectorFeb 25Sale50.5856,0232,833,663112,750Mar 01 09:36 PM
Lockwood Kristina SGeneral Counsel and SecretaryFeb 22Sale52.901,25166,18121,164Feb 23 07:07 PM
JACOBS WILLIAM IDirectorFeb 16Sale54.5150027,25564,401Feb 18 08:07 PM
Lockwood Kristina SGeneral Counsel and SecretaryFeb 10Sale53.7552027,95021,164Feb 11 09:36 PM
FTNT Fortinet, Inc. daily Stock Chart
FTNT [NASD]
Fortinet, Inc.
IndexS&P 500 P/E93.91 EPS (ttm)3.33 Insider Own11.40% Shs Outstand163.50M Perf Week-0.67%
Market Cap50.34B Forward P/E67.91 EPS next Y4.60 Insider Trans-0.68% Shs Float133.78M Perf Month-7.20%
Income554.50M PEG5.58 EPS next Q1.15 Inst Own70.70% Short Float1.94% Perf Quarter-0.87%
Sales3.13B P/S16.10 EPS this Y54.70% Inst Trans0.29% Short Ratio1.99 Perf Half Y21.79%
Book/sh6.84 P/B45.69 EPS next Y17.82% ROA10.60% Target Price374.82 Perf Year113.29%
Cash/sh19.38 P/C16.13 EPS next 5Y16.84% ROE55.40% 52W Range143.63 - 371.77 Perf YTD-13.04%
Dividend- P/FCF40.19 EPS past 5Y129.90% ROI55.40% 52W High-15.93% Beta1.20
Dividend %- Quick Ratio1.70 Sales past 5Y20.80% Gross Margin76.90% 52W Low117.60% ATR15.47
Employees9700 Current Ratio1.80 Sales Q/Q33.20% Oper. Margin19.30% RSI (14)42.89 Volatility4.60% 4.68%
OptionableYes Debt/Eq0.90 EPS Q/Q30.50% Profit Margin17.70% Rel Volume0.97 Prev Close307.88
ShortableYes LT Debt/Eq0.88 EarningsFeb 03 AMC Payout0.00% Avg Volume1.30M Price312.54
Recom2.20 SMA20-6.81% SMA50-5.94% SMA20011.82% Volume1,257,932 Change1.51%
Oct-05-21Initiated Wells Fargo Overweight $380
Sep-28-21Reiterated Cowen Outperform $335 → $385
Sep-21-21Initiated Stifel Buy $355
Jul-30-21Reiterated Wedbush Outperform $240 → $310
Jul-30-21Reiterated RBC Capital Mkts Outperform $208 → $248
Jul-30-21Reiterated Raymond James Outperform $280 → $295
Jul-30-21Reiterated Morgan Stanley Equal-Weight $187 → $230
Jul-30-21Reiterated Mizuho Neutral $250 → $260
Jul-30-21Reiterated KeyBanc Capital Markets Overweight $297 → $324
Jul-30-21Reiterated Deutsche Bank Hold $242 → $250
Jul-30-21Reiterated Cowen Outperform $305 → $335
Jul-30-21Reiterated BTIG Research Buy $291 → $305
Jul-30-21Reiterated BMO Capital Markets Market Perform $275 → $300
Jun-29-21Downgrade Monness Crespi & Hardt Buy → Neutral
May-27-21Initiated Cowen Outperform $230
Mar-16-21Resumed Credit Suisse Neutral $165
Mar-10-21Reiterated Monness Crespi & Hardt Buy $175 → $195
Feb-05-21Upgrade KeyBanc Capital Markets Sector Weight → Overweight $185
Feb-05-21Reiterated Monness Crespi & Hardt Buy $155 → $175
Jan-26-21Resumed Evercore ISI Outperform $180
Jan-14-22 09:38PM  
05:45PM  
01:38PM  
11:19AM  
Jan-13-22 07:15AM  
Jan-12-22 07:11PM  
09:38AM  
09:00AM  
06:00AM  
Jan-11-22 05:38PM  
Jan-10-22 09:41AM  
08:02AM  
07:14AM  
Jan-07-22 05:45PM  
Jan-04-22 04:45PM  
Jan-03-22 10:01AM  
09:00AM  
06:00AM  
Dec-31-21 05:50PM  
10:13AM  
09:56AM  
09:50AM  
07:28AM  
Dec-30-21 09:55AM  
Dec-29-21 09:58AM  
Dec-28-21 06:00PM  
11:10AM  
09:32AM  
07:20AM  
06:38AM  
Dec-27-21 10:27AM  
09:46AM  
05:56AM  
Dec-24-21 08:00AM  
Dec-23-21 06:31PM  
08:06AM  
Dec-22-21 02:18PM  
06:07AM  
Dec-21-21 09:34AM  
Dec-20-21 05:50PM  
09:00AM  
06:10AM  
Dec-17-21 08:38PM  
05:38PM  
07:12AM  
Dec-14-21 04:45PM  
01:38PM  
08:00AM  
Dec-13-21 08:45PM  
05:50PM  
04:39PM  
12:55PM  
09:52AM  
06:29AM  
Dec-10-21 09:11PM  
08:00PM  
10:45AM  
Dec-09-21 12:38PM  
Dec-08-21 10:35PM  
01:38PM  
12:46PM  
09:10AM  
Dec-03-21 12:33PM  
Dec-01-21 05:46AM  
Nov-30-21 04:10PM  
06:08AM  
Nov-24-21 08:45AM  
Nov-22-21 01:04PM  
Nov-19-21 03:08PM  
Nov-18-21 11:25AM  
04:00AM  
Nov-17-21 09:00AM  
Nov-16-21 09:00AM  
Nov-15-21 09:00AM  
Nov-12-21 08:30AM  
Nov-08-21 11:27AM  
03:00AM  
Nov-05-21 04:20PM  
09:17AM  
08:21AM  
07:21AM  
Nov-04-21 11:02PM  
06:15PM  
04:05PM  
09:00AM  
Nov-03-21 09:00AM  
Nov-02-21 08:00AM  
Oct-28-21 05:19PM  
03:06PM  
Oct-25-21 05:23PM  
Oct-22-21 05:50PM  
09:08AM  
Oct-19-21 11:30AM  
09:00AM  
Oct-18-21 01:47PM  
01:39PM  
12:53PM  
11:56AM  
11:10AM  
09:00AM  
Fortinet, Inc. provides broad, integrated, and automated cybersecurity solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers FortiGate hardware and software licenses that provide various security and networking functions, including firewall, intrusion prevention, anti-malware, virtual private network, application control, web filtering, anti-spam, and wide area network acceleration. The company also provides FortiSwitch product family that offers secure switching solutions for connecting customers their end devices; FortiAP product family, which provides secure wireless networking solutions; FortiExtender, a hardware appliance; FortiAnalyzer product family, which offers centralized network logging, analyzing, and reporting solutions; and FortiManager product family that provides central and scalable management solution for its FortiGate products. It offers FortiWeb product family provides web application firewall solutions; FortiMail product family that secure email gateway solutions; FortiSandbox technology that delivers proactive detection and mitigation services; FortiClient that provides endpoint protection with pattern-based anti-malware, behavior-based exploit protection, web-filtering, and an application firewall; FortiToken and FortiAuthenticator product families for multi-factor authentication to safeguard systems, assets, and data; and FortiEDR/XDR, an endpoint protection solution that provides both comprehensive machine-learning anti-malware execution and real-time post-infection protection. The company provides security subscription, technical support, professional, and training services. It sells its security solutions to channel partners and directly to various customers in telecommunications, technology, government, financial services, education, retail, manufacturing, and healthcare industries. It has strategic alliance with Linksys. The company was founded in 2000 and is headquartered in Sunnyvale, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sim JudithDirectorDec 31Option Exercise0.00244026,637Jan 03 05:47 PM
NEUKOM WILLIAM H.DirectorDec 31Option Exercise0.00244055,908Jan 03 05:46 PM
Hu Jean X.DirectorDec 31Option Exercise0.0024404,411Jan 03 05:45 PM
Hsieh MingDirectorDec 31Option Exercise0.0024409,138Jan 03 05:44 PM
GOLDMAN KENNETH ADirectorDec 31Option Exercise0.0024401,895